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ABSTRACT
New methods for studying enzymes and enzyme inhibition using capillary
electrophoresis (CE) were developed and applied. Because CE is a separation technique, spectral
interference is minimized by separation of substrates, products, inhibitors, and sample matrix
components. Two types of CE enzyme assays were explored in this dissertation research. The
first assay was based on optically gated vacancy capillary electrophoresis (OGVCE) with laserinduced fluorescence detection (LIF). This approach involves periodic photobleaching of
fluorescent substrates and products. The initial goal of the study was to develop an assay for
adenosine deaminase (ADA). A fluorescent ADA substrate was synthesized; however, the
substrate was unusually photostable and could not be photobleached. In Chapter 2, a comparative
study is presented that quantified the photostability of the fluorescent ADA substrate relative to
other fluorophores that have been used for OGVCE in order to obtain a better understanding of
the ideal properties of a dye for OGVCE assays. The development of an off-column CE assay for
measuring acetyl coenzyme A carboxylase holoenzyme (holo-ACC) activity and inhibition is
presented in Chapter 3. The two reactions catalyzed by the holo-ACC components, biotin
carboxylase (BC) and carboxyltransferase (CT), were simultaneously monitored in the assay,
which required successful separation of two substrates and two products using micellar
electrokinetic chromatography (MEKC). Additionally, a previously reported off-column CE
assay for only the CT component of ACC was optimized, and an off-column CE assay for only
the BC component of ACC was developed. Finally, the CE-based enzyme assays developed in
Chapter 3 were used for screening of botanical extracts against holo-ACC, BC and CT (Chapter
4). Compounds known to be present in the botanical extracts that inhibited holo-ACC were
selected based on a detailed literature search and tested for inhibition of holo-ACC, BC and CT.

xii

Synthetic compounds selected based on ligand homology studies were also tested for inhibition
of holo-ACC. These CE assays were simple, off-column methods, where spectral interference
and other limitations of previous methods were greatly reduced. The development of methods
that can directly monitor reactants and products for multiple enzyme-catalyzed reactions will
have impact beyond the enzymes presented in this dissertation.
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CHAPTER 1. INTRODUCTION
1.1.

Enzyme Catalysis
Enzymes are proteins found in all living systems that function as catalysts for chemical

reactions. Enzymes are essential for the function and regulation of cells, tissues, and organs [1].
At any point in time, there are thousands of chemical reactions occurring in living cells, and
nearly all of them are catalyzed by enzymes. Therefore, enzymes are vital to the function of our
bodies, and improper functioning of enzymes can lead to illness and disease. Like all proteins,
enzymes are composed of one or more chains of amino acids. The structural organization of a
protein is described using four levels known as the primary, secondary, tertiary, and quaternary
structure. The linear sequence of amino acids, which is known as the primary structure, is
genetically determined and unique to each protein. In the primary structure, the amino acids are
linked by amide bonds [1, 2]. The secondary structure is a three-dimensional arrangement of the
protein, which is driven by hydrogen bonding [1, 2]. The two most common types of secondary
structure are α-helices and β-pleated sheets; however, other structures are also possible. Proteins
usually adopt specific conformations in which hydrophobic amino acids are protected from the
aqueous surroundings in a biological system [1]. The protein can assume a more compact threedimensional structure, which is the tertiary structure. The tertiary structure is known as the active
form of a protein (native structure), and enzymes consisting of a single polypeptide chain
function in this conformation. Enzymes consisting of two or more polypeptide chains are
referred to as multi-subunit enzymes and cannot function properly without the necessary subunits
[1]. Each subunit is a polypeptide chain that has assumed a tertiary structure. The quaternary
structure is based upon how the multiple polypeptide chains are arranged, where the arrangement
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of polypeptide chains is based on noncovalent forces such as hydrogen bonds, ionic bonds, van
der Waals interactions, and hydrophobic interactions [1, 2].
For every enzyme-catalyzed reaction, the enzyme must bind to a substrate, and in many
cases there are two substrates and more than one reaction product. In enzyme-catalyzed
reactions, the enzyme lowers the energy needed for a substrate to be converted to a product [1].
Enzymes are selective for their substrates, and substrates and enzymes have structures that
complement each other. The active site of the enzyme typically is a crevice or cleft within the
enzyme where the substrate binds and catalysis occurs. Typically, this binding occurs through
weak attractions such as hydrogen bonds, ionic bonds, and van der Waals interactions [1-3].
Some enzymes require cofactors in order to function. Cofactors are nonprotein
components such as metals and organic molecules, which are bound to the enzyme and are
essential to its function [1, 3]. Cofactors that are required for the catalytic function of enzymes
are also known as coenzymes. Many coenzymes are covalently bound to the enzyme and are
referred to as prosthetic groups. The term holoenzyme is used to describe the catalytically active
complex of protein and coenzyme(s) or prosthetic group(s), and the term apoenzyme is used to
describe the catalytically inactive enzyme, which does not have the coenzyme(s) or prosthetic
groups bound to it. A few common coenzymes are nicotinamide adenine dinucleotide (NAD+),
coenzyme A (CoA), and biotin [3].
1.1.1. Michaelis-Menten Kinetics
Chemical kinetics is the overall study of chemical reaction rates [3]. Chemical kinetics,
specifically for enzyme-catalyzed reactions is known as enzyme kinetics [3]. Enzyme kinetics is
used to study the roles of enzymes in metabolic reactions and determine how catalysis is
accomplished. Enzyme kinetics provides valuable information such as the maximum reaction
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velocity reached during catalysis, binding affinities of substrates to enzymes, and how the
enzyme responds to different substrate concentrations [3]. Additionally, information obtained
from enzyme kinetics experiments can be used to determine the mechanism by which catalysis
occurs [3]. Enzyme kinetics is commonly described by the Michaelis-Menten model, which was
proposed by Lenore Michaelis and Maud L. Menten in 1913 [4]. Equation 1.1 shows the typical
progression of an enzyme-catalyzed reaction where each step is generally regarded as reversible.
Once the enzyme (E) binds the substrate (S), an enzyme-substrate (ES) complex is formed,
which is converted to an enzyme-product (EP) complex. Then, the reaction proceeds to yield free
enzyme and product (P) once the enzyme-product complex dissociates.
↔

↔

↔

(1.1)

Simplifications of Equation 1.1 described by the Michaelis-Menten model rely on several
assumptions. The binding of the enzyme and substrate to form the enzyme-substrate complex
and the dissociation of the complex back to enzyme and substrate are assumed to be in
equilibrium. This kinetic mechanism was analyzed and extended by Briggs and Haldane in 1925,
who proposed the steady-state assumption, which is widely used for the determination of enzyme
kinetics [5]. The steady-state assumption states that the concentration of the enzyme-substrate
complex ([ES]) is constant because the enzyme-substrate complex forms as rapidly as it
disappears [1, 3]. Therefore, [ES] is assumed to be constant throughout the time interval used to
perform kinetic studies [1, 3]. Another assumption that is made for the simplification of
Michaelis-Menten kinetics is that the reverse reaction (formation of the enzyme-substrate
complex from enzyme plus product) is negligible [1, 3]. This is because the initial velocity of the
reaction is observed (immediately after the enzyme and substrate are mixed). At these early time
points, there is likely no conversion of the enzyme plus product to form the enzyme-substrate
3

complex because [P] is very low. Because [ES] is constant and the formation of product is
irreversible, the velocity, or rate, of the enzymatic reaction is also constant. The rate is measured
either as disappearance of substrate or formation of product. Using the aforementioned
assumptions, the enzyme-catalyzed reaction scheme is simplified to Equation 1.2.
↔

→

(1.2)

The first step is reversible because the enzyme-substrate complex can dissociate back to enzyme
plus substrate, and the association and dissociation constants for this step are k1 and k-1,
respectively. The dissociation constant for the second step is kp. The ratio of the constants, (k-1 +
kp/k1), is defined as the Michaelis constant, Km, which is the substrate concentration at which the
reaction rate is half of the maximum reaction rate [1]. The maximum rate of the reaction is
defined as Vmax. The Vmax is reached once the enzyme is saturated with substrate [1]. In other
words, all of the enzyme is in the form of the enzyme-substrate complex. These two constants
along with the initial concentration of the substrate determine the initial rate of the reaction (𝑣),
according to the Michaelis-Menten equation (Equation 1.3).
𝑣

(1.3)

The Michaelis-Menten equation can be fit to a plot of 𝑣 versus [S] called a substrate
saturation curve, also known as a Michaelis-Menten plot (Figure 1.1). Using this plot, Vmax and
Km can be determined as shown in Figure 1.1. Linear plots derived from the Michaelis-Menten
equation can be used to further analyze enzymatic reactions. The Lineweaver-Burk double
reciprocal plot is widely used (Figure 1.2). This plot is generated after taking the reciprocal of
both sides of the Michaelis-Menten equation, which yields Equation 1.4.
𝑣

(

)(

)
4

(1.4)

This equation is linear with a slope of Km/Vmax and a y-intercept of 1/Vmax (Figure 1.2). In
practice, nonlinear regression is used to determine Km and Vmax more precisely using computer
programs designed to fit the rate versus concentration data to Equation 1.3 [6].

Vmax

Vmax/2

0
m

[S]

Figure 1.1. Michaelis-Menten plot. A plot of the reaction rate (𝑣) versus substrate concentration,
[S], where Vmax is the maximum rate of the reaction and Km is the Michaelis constant, which is
the substrate concentration at which the reaction rate is half of Vmax .

Slope = Km/Vmax

1/

m

1/Vmax

0

Figure 1.2. Lineweaver-Burk plot. A plot of the inverse of the rate versus the inverse of
substrate concentration. Km and Vmax are defined in the text and in Figure 1.1.
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1.2.

Enzyme Inhibition
Because enzymes play a central role in important biochemical processes and metabolic

pathways, it is important to understand the inhibition of enzymes. Enzyme inhibitors are targets
for the development of a wide range of treatments for diseases such as cancer and diabetes [7, 8].
Studying enzyme inhibition is also important for understanding the mechanisms of enzymes.
Additionally, enzyme inhibitors are used in agriculture as herbicides [9, 10]. Biological systems
naturally regulate catalysis using enzyme inhibition. In 2000, Drews et al. reported that about
30% of drugs used clinically are therapeutically effective due to enzyme inhibition [11]. In 2002,
Hopkins et al. reported that half of newly developed drugs inhibited target enzymes [12].
Enzyme inhibitors stop enzymes from catalyzing reactions or decrease the reaction rate
[1, 7]. Inhibition of an enzyme-catalyzed reaction is analyzed using enzyme kinetics in order to
determine binding affinities of an enzyme to an inhibitor, rates of inhibited reactions, inhibition
constants, and types of inhibition. This information is used during the drug discovery process
when potential inhibitors are screened for inhibition of target enzymes [7, 8]. Therefore,
understanding enzyme kinetics and identifying enzyme inhibitors are both essential to the
process of drug discovery.
Types of Inhibition
Enzyme inhibitors are classified as reversible and irreversible inhibitors [1-3].
Irreversible inhibitors form permanent, covalent bonds with the enzyme, and reduce or eliminate
its activity. Reversible inhibitors bind noncovalently to the enzyme, and the enzyme-inhibitor
complex dissociates very rapidly. The three subtypes of reversible enzyme inhibitors are
competitive, noncompetitive and uncompetitive inhibitors.
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Competitive inhibitors compete with the substrate for the active site of the enzyme and
bind reversibly [1-3]. At high concentrations of substrate, the inhibitor is less likely to bind to the
enzyme [1-3]. In competitive inhibition, the inhibitor affects Km while Vmax remains unaffected
by the inhibitor as indicated in Equation 1.5 [1].
𝑣

(1.5)
(

)

In this modified version of Equation 1.3, Km is multiplied by (1 + ([I]/Kis), so the overall reaction
rate, 𝑣, will be lower relative to an uninhibited reaction (Equation 1.3). At high concentrations of
substrate, 𝑣 is unaffected by [I]. The inhibition kinetic constant, Kis, can be determined by
nonlinear fitting of Equation 1.5 to a plot of 𝑣 versus [I]. Competitive inhibition can be
identified using a Lineweaver-Burk plot (Figure 1.3). As shown in Figure 1.3, competitive
inhibition results in lines that have the same y-intercept but different x-intercepts for plots of
experiments using different inhibitor concentrations.

[I]

Control

0

Figure 1.3. Lineweaver-Burk plot for competitive inhibition. A plot of the inverse of reaction
rate versus the inverse of substrate concentration for a reaction without inhibitor (control) and
two reactions with different inhibitor concentrations [I].
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Uncompetitive inhibitors bind to the ES complex only [1-3]. Uncompetitive inhibitors
affect Km and Vmax [1]. In the case of uncompetitive inhibition, the rate equation is Equation 1.6.
𝑣

(1.6)
(

)

The inhibition constant, Kii, is determined by nonlinear fitting of Equation 1.6. The LineweaverBurk plot for uncompetitive inhibition shows that both the x-intercept and y-intercept change
with increasing [I], while the slope remains the same (Figure 1.4). As shown in Figure 1.4,
uncompetitive inhibition results in a Lineweaver-Burk plot with parallel lines.

[I]

Control

0

Figure 1.4. Lineweaver-Burk plot for uncompetitive inhibition. A plot of the inverse of reaction
rate versus the inverse of substrate concentration for a reaction without inhibitor (control) and
two reactions with increasing inhibitor concentrations [I].

Noncompetitive inhibitors can bind to the enzyme or the ES complex [1-3]. Unlike
competitive inhibition, noncompetitive inhibition cannot be overcome by high substrate
concentration [1-3]. There are two types of noncompetitive inhibition, pure and mixed. Pure
8

noncompetitive inhibition, where the binding of the inhibitor to the enzyme does not affect the
binding of the substrate to the enzyme, is relatively uncommon. The rate equation for pure
noncompetitive inhibition is Equation 1.7.
𝑣

(1.7)
(

)

Pure noncompetitive inhibition decreases Vmax, but does not affect the Km [1]. The LineweaverBurk plot for pure noncompetitive inhibition shows that the y-intercept and slope increase with
increasing [I], while the x-intercept remains unaffected.

[I]

Control

0

Figure 1.5. Lineweaver-Burk plot for pure noncompetitive inhibition. A plot of the inverse of
reaction rate versus the inverse of substrate concentration for a reaction without inhibitor
(control) and two reactions with increasing inhibitor concentrations [I].

In mixed noncompetitive inhibition, the binding of the inhibitor by the enzyme affects the
binding of the substrate by the enzyme [1]. This can occur because the binding sites of the
inhibitor and substrate are in close proximity or the binding of the inhibitor by the enzyme
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induces a conformational change that impacts binding of the substrate. Equation 1.8 is the rate
equation for mixed noncompetitive inhibition [1].
𝑣

(1.8)
(

)

(

)

As shown in Equation 1.8, there are two inhibition constants, Kii and Kis. When Kis > Kii, the lines
of the Lineweaver-Burk plot will cross below the x-axis (not shown); however, when Kii < Kis,
the lines will cross above the x-axis as shown in Figure 1.6. In mixed noncompetitive inhibition,
both Km and Vmax are different when comparing the inhibited reactions to the uninhibited reaction
[1].

[I]

Control

0

Figure 1.6. Lineweaver-Burk plot for mixed noncompetitive inhibition. A plot of the inverse of
reaction rate versus the inverse of substrate concentration for a reaction without inhibitor
(control) and two reactions with increasing inhibitor concentrations [I]. As shown in the plot, the
slope of the line increases with increasing inhibitor concentration.

Substrate and product inhibition are also possible [2, 3]. Product inhibition typically
occurs because the product is a substrate for the reverse reaction [2]. Therefore, the product can
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bind to the enzyme and act similarly to a competitive inhibitor. Substrate inhibition occurs when
the substrate or cofactor also has affinity for a non-active site on the enzyme. At high
concentrations of the substrate or cofactor, binding to the enzyme can occur, resulting in
substrate inhibition [3].
1.2.2. Botanicals as Enzyme Inhibitors
There are many different approaches that are used to identify enzyme inhibitors. Many of
these approaches involve trial and error, such as high-throughput screening techniques, which
involve screening libraries of synthetic molecules that may or may not inhibit the target enzyme
[11]. Another approach involves screening botanical extracts for inhibition of targeted enzymes.
For centuries, the medicinal properties of various botanicals have been investigated. A review of
the literature shows that over the years, plants have had a major role as therapeutics for various
diseases in the form of dietary supplements and drugs [13, 14], and botanical extracts have
played a role in drug discovery [14-20]. In fact, a comprehensive study conducted by Newman et
al. in 2006, indicated that 52% of 974 small molecule-based drugs developed from 1981-2006
were either natural products, derived from natural products, or synthetics that mimicked a natural
product or had a natural product pharmacophore [20]. For example, metformin, which is
commonly used to treat diabetes, is a biguanide derived from isoamylene guanidine which is
found in in French lilac (Galega officinalis) [21]. Galanthamine (reminyl, galanta mind), which
is used to treat Alzheimer’s disease, can be isolated from plants such as the snow drop flower,
daffodil, and spider lily [22]. It is effective at slowing the process of neurological degeneration
because it inhibits the enzyme acetylcholinesterase [22-25]. A drug used to treat human
immunodeficiency syndrome (HIV), calanolide A, can be isolated from a Malaysian rainforest
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tree (Calophyllum lanigerum) [26-28] and is effective against type-1 HIV by inhibiting nonnucleoside reverse transcriptase [28-30].
1.3.

Enzyme Assays
Enzyme assays are performed to determine enzyme activity or the ability of an enzyme to

catalyze the reaction of substrates to form products. This is done by monitoring the accumulation
of product or reduction of substrate. Enzyme assays are frequently performed in chemical and
biological sciences (including biomedicine), especially as part of the drug discovery process [13, 7]. Most traditional enzyme assays are carried out in cuvettes or microtiter wells, and the
progress of the reaction is analyzed by using UV-Vis absorbance detection to measure the
change in substrate or product absorbance over time [31]. Fluorescence detection is also
commonly used for microplate reader based assays. Assays based on UV absorbance or
fluorescence with UV excitation are prone to spectral interference by inhibitors and biological
sample matrices, which is a significant limitation [31]. Some enzymes do not have a substrate or
product that can be measured directly by absorbance or fluorescence detection, and in many of
these cases, substrates or products are labeled with radioactive isotopes. Assays based on
radiolabelling have significant disadvantages because they can be expensive and complex in
practice due to health, waste and regulatory issues [31]. Another approach used when substrates
and products can’t be detected directly is the use of enzyme-coupled assays. In enzyme-coupled
assays, the reactions of interest are coupled to other enzyme catalyzed reactions. The auxiliary
enzymes used are referred to as coupling enzymes. Typically, a product for the reaction of
interest will serve as a substrate for another enzyme-catalyzed reaction that can be monitored.
Often, these assays involve the reduction of NAD(P)+ to yield NAD(P)H or the oxidation of
NAD(P)H to produce NAD(P)+. Both processes can be monitored using absorbance or
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fluorescence detection, which makes the use of these coupling reactions effective. Assays based
on enzyme-coupled reactions are indirect and susceptible to false positives for inhibition studies
because a potential inhibitor could be inhibiting the coupling enzymes, which is a major
drawback [31].
Capillary Electrophoresis-Based Enzyme Assays
Capillary electrophoresis (CE) is a well-established separation technique that has been
around for over 30 years. In 1981, Jorgenson and Luckas reported separations of amino acids and
peptides using open glass capillaries and fluorescence detection [32]. Since then, this technique
has been used for a wide array of applications including DNA sequencing, due to its advantages
over other separation techniques, including high separation efficiency, simplicity, small sample
volumes (nL) and rapid analysis times [33]. Additionally, CE can be coupled with UV-Vis
absorbance, laser-induced fluorescence (LIF), mass spectrometry (MS), and electrochemical
detection methods [34, 35]. This technique (Figure 1.7) employs a capillary which typically has
an inner diameter ranging from 50 to 100 µm with a 360 µm outer diameter. Both ends of the
capillary are immersed in buffer vials that contain electrodes, which are connected to a high
voltage power supply. When a voltage is applied across the capillary, the analytes separate based
on their electrophoretic mobility, which is related to the charge-to-size ratio of analytes.
It has been demonstrated that CE can be used effectively for performing quantitative enzyme
assays and studying enzyme inhibition [36-39]. Using CE to investigate enzyme-catalyzed
reactions has an advantage over traditional enzyme assays, which are often limited by spectral
interference. Because CE is an electrophoretic separation technique, spectral interference is
reduced by separation of substrates, products, inhibitors and sample matrix components. In
addition, eliminating spectral interference allows direct monitoring of substrate depletion and
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product formation in contrast to enzyme-coupled assays, which can result in false positives.
Furthermore, when monitoring substrate depletion and/or product formation directly, radiolabels
are not needed, which eliminates cost, health, waste and regulatory issues.

Data
acquisition

Capillary

Inlet +
buffer

Detection
system

-

Sample

Outlet
buffer

Electroosmotic flow
+ High voltage power supply
Figure 1.7. Schematic of a basic capillary electrophoresis system.

Enzyme assays based on CE can be homogeneous assays or heterogeneous assays. In
homogenous assays, all assay components are in the solution phase. Homogeneous assays are
further

subcategorized:

off-column

(offline),

on-column

(online),

and

post-column.

Heterogeneous assays refer to assays in which one of the assay components is immobilized,
forming a microreactor [40]. Typically, the enzyme is immobilized inside the capillary on the
capillary wall or on support surfaces such as silica beads or magnetic beads. The substrate is
introduced into the capillary in the running buffer, and once the substrate and enzyme mix,
product is formed. The product migrates through the capillary and is detected downstream.
Heterogeneous assays have been extensively reviewed by Krenkova and Foret [40]. The research
presented in this dissertation is focused on homogenous assays, and the two major types of
homogenous assays, on-column and off-column, will be described.
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1.3.2. On-Column CE Assays
In on-column CE assays, the enzyme-catalyzed reaction is initiated inside the capillary.
This is generally carried out by injecting a plug of enzyme and a plug of substrate into the
capillary and allowing them to mix, initiating the reaction. The first on-column CE enzyme assay
was demonstrated by Bao and Regnier in 1992 [41]. A plug of enzyme was injected into a
capillary filled with the substrate and a coenzyme required for the reaction. Product formation
occurred as the enzyme migrated through the capillary and was detected by a downstream
absorbance detector. The product formation was represented by a plateau in the resulting
electropherogram. This type of CE-based assay was later termed electrophoretically mediated
microanalysis (EMMA), and this format was defined as continuous engagement EMMA [42]. In
continuous engagement EMMA, the substrate is often fluorogenic, which is a substrate that is
nonfluorescent but produces a fluorescent product that can be detected by laser-induced
fluorescence. Another format, in which the enzyme and substrate are injected in separate plugs
and allowed to mix electrophoretically, was defined as transient engagement EMMA. In transient
engagement EMMA, the plug with the slowest electrophoretic mobility is injected first. When
the separation voltage is applied, the faster moving plug will pass the slower moving plug,
initiating the enzymatic reaction, which results in a product peak being detected downstream
[42].
Whisnant et al. used capillary electrophoresis with laser-induced fluorescence detection
(CE-LIF) to study enzyme inhibition using a combination of both transient and continuous
engagement EMMA [43]. The capillary was first filled with the fluorogenic substrate, AttoPhos,
and running buffer. Then the enzyme, alkaline phosphatase, and the inhibitor, theophylline, were
injected into the capillary as separate plugs. A constant potential was applied, and the enzyme
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and inhibitor migrated through the substrate-filled capillary. As the reaction proceeded,
fluorescent product was formed and detected as a plateau by a downstream LIF detector. The
inhibitor plug was indicated by a negative peak in the plateau because the product formation
decreased as the inhibitor zone mixed with the enzyme-substrate complex. The inhibition of
alkaline phosphatase by different types of inhibitors was also studied using the same method
[44]. More information about on-column CE assays can be found in reviews [37, 38]; this
dissertation work focusses on off-column CE assays.
1.3.3. Off-column CE assays
In off-column CE assays the substrates, products, and inhibitors are mixed outside of the
capillary, but one component is left out of the initial mixture, either the enzyme or the substrate.
To initiate the reaction, the enzyme or substrate is added to the reaction mixture. Then a plug of
the reaction mixture is sampled periodically by the CE instrument. Substrate depletion or product
formation is monitored in the resulting electropherograms. A representative electropherogram for
an off-column CE assay is shown in Figure 1.8. In the case where an inhibitor is present in
solution, the substrate depletion and product formation will occur at decreased rates in
comparison to a control assay. These types of assays have been performed in capillaries and
microchips [37, 38]. Off-column assays are used for kinetic studies when the enzyme-catalyzed
reaction is slow enough to be monitored periodically over a time frame that can range from
several minutes to several hours or days.
The first off-column homogeneous CE enzyme assay for the determination of enzyme
activity was demonstrated by Krueger et al. in 1991 for the analysis of endoproteinase Arg C
[45]. In this assay, the adrenocorticotrophic hormone (ATCH (1-39)) peptide was incubated with
endoproteinase Arg C in a reaction vial, and the mixture was periodically injected into the
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capillary in order to monitor enzyme-catalyzed hydrolysis of 3 peptide bonds. In 1992, Landers
et al. reported the determination of bacterial chloramphenicol acetyl transferase (CAT) activity
using CE [46]. In this assay, the enzyme was incubated with acetyl coenzyme A and
chloramphenicol, and after the incubation period, the mixture was injected into the capillary.
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Figure 1.8. Sketch of electropherograms for the progress of a simple off-column CE enzyme
assay where the depletion of substrate and formation of product are observed in 3 consecutive
injections of the reaction mixture. Electropherogram A represents the first injection, B represents
the second injection, and C represents the third injection.

The formation of products, coenzyme A and diacetyl chloramphenicol, and depletion of the
substrates were observed. Pascual et al. reported CE-based studies of glutathione peroxidase
activity where the separation and quantitation of reduced and oxidized glutathione were observed
by CE [47]. In this study, sodium dodecyl sulfate was used to aid in the separation.
In off-column CE enzyme inhibition assays, the inhibitor is included in the reaction
mixture. After the enzyme-catalyzed reaction is initiated, the mixture is injected into the CE
instrument. Product formation in the inhibited reaction is compared to the product formation in a
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control assay (no inhibitor present) using the resulting electropherograms. The first off-column
CE enzyme inhibition assay was reported by Hoffmann et al. in 1995 [48]. The inhibition of
dipeptidyl peptidase IV (DP-IV) by anti-DP IV antibodies was investigated using CE. Since that
report, CE has been used to study the inhibition many of other enzymes. For example, in 1998,
Kanie et al. studied the inhibition of galactosyltransferase using CE [49]. The GalTase-catalyzed
transfer of uridine 5’-phosphonate galactose (UDP-gal), the substrate, to 4-methylyumbelliferyl
2-acetamido-2-deoxy-β-D-glucopyranoside (MU-GlcNAc), the product, was monitored by CE
with absorbance detection. For the inhibition studies, UDP, a known GalTase inhibitor, was
added to the reaction mixture and the inhibited reaction was monitored by CE [49]. In 2001,
Change et al. developed a CE method with absorbance detection for studying the inhibition of
angiotensin converting enzyme (ACE) by cultivated hot water Cordyceps sinensis extracts [50].
In order to decrease the analysis time for off-column assays, short end injection
techniques have been developed [51-54]. In short end injection techniques, the sample vial is
placed at the outlet end of the capillary, which is closer to the detection window than the inlet
end. After injecting the sample from the outlet end, the separation is carried out using reverse
polarity, which results in bulk electroosmotic flow toward the inlet end of the capillary.
1.3.4. Optical Gating Injections for CE
Optically gated vacancy capillary electrophoresis (OGVCE) is a technique where a
solution containing a fluorescent compound or fluorescently labeled compound is continuously
electrophoresed through the capillary and periodically photobleached at specific time intervals.
This technique offers a potential advantage for development of CE enzyme assays because
almost any fluorescent substrate with a high turnover rate that produces and is capable of being
photobleached can be used with OGVCE. In OGVCE, a fluorescent substrate is incubated with
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an enzyme offline, and the progress of the reaction is monitored as the mixture is continuously
electrophoresed through a capillary and the reaction is monitored. Fluorogenic substrates are not
required. Both the substrate and the product can be fluorescent. The need for a fluorogenic
substrate limits the range of enzymes that can be studied using previously developed CE assays.
The instrument for OGVCE experiments is shown in Figure 1.9. The capillary is filled
with the fluorescent compound during the entire experiment. The photobleaching beam from the
laser is blocked by a computer-controlled shutter. When the shutter is opened, the bleaching
PMT
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Figure 1.9. Schematic of the instrumentation for optically gated vacancy capillary
electrophoresis (OGVCE).

beam is focused on the capillary. As the fluorescent dye migrates through the capillary, the
opening of the shutter allows the high-powered beam to photobleach the dye at position F1 in the
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capillary window. The fluorescence emission is collected by a microscope objective at position
F2 in the capillary window, and the photobleached zone is observed as a negative peak (vacancy)
in the resulting electropherogram (Figure 1.10). Additionally, an optical fiber is used to collect
light each time the shutter is opened and direct it to the PMT for detection. This light creates a
positive peak in electropherograms and represents the time at which the vacancies were created
(Figure 1.10). When two dyes are present in solution, two separate negative peaks are observed
in the electropherogram.

Figure 1.10. Schematic of the OGVCE method. A fluorescent dye is continuously
electrophoresed through capillary, and the shutter is closed initially (A). When the shutter is
opened, a photobleached zone is generated at F1, and the scattered light collected by an optical
fiber is detected as a positive peak in the electropherogram (B). Then, the photobleached dye
migrates to F2, where it is detected as a negative peak in the electropherogram (C). Steps B and
C are repeated throughout the duration of the experiment (D and E).

In an off-column OGVCE enzyme assay, the enzyme is incubated with a fluorescent
substrate in a reaction vial before electrophoresis is initiated. Then, the reaction mixture is
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continuously sampled by electrophoresis as photobleaching occurs. As the enzyme catalyzes the
reaction, two negative (vacancy) peaks, corresponding to the substrate and product, are observed
in the resulting electropherogram (Figure 1.11). The fluorescent substrate and product peaks
migrate at different rates due to their electrophoretic mobilities. As the reaction continues, the
substrate peak decreases over time and the product peak increases. Figure 1.11 displays a
schematic of an electropherogram for the progress of an OGVCE enzyme assay. Employing
OGVCE injections offers advantages over traditional CE sample injections, because the reaction
can be monitored every few seconds, depending on the difficulty of the separation [55, 56].
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Figure 1.11. Sketch of an electropherogram for an OGVCE enzyme assay. After photobleaching
of the reaction mixture occurs, the fluorescent substrate and product are detected as separate
negative peaks in the electropherogram. The depletion of substrate and formation of product are
observed as the reaction proceeds.

1.3.5. MEKC Modifications for Off-Column CE Assays
Micellar electrokinetic chromatography (MEKC), which was first reported by Terabe et
al. in 1984 [57], has been widely used for the enhancement of CE separations [58, 59]. In
MEKC, an ionic surfactant is added above its critical micelle concentration (CMC) to the
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running buffer for a CE separation. The CMC is a concentration above which the surfactant
molecules form micelles, which are aggregates of surfactants dispersed in a liquid colloid.
Generally, micelles have a hydrophobic tail and hydrophilic head. Although the micelles are not
stationary, they are similar to the stationary phase in chromatography and are referred to as a
pseudostationary phase in MEKC. The surrounding solution is analogous to the mobile phase.
Adding micelles to a CE running buffer is simple and can result in highly efficient separations
and short analysis times [58, 59]. The most popular surfactant used for MEKC is sodium dodecyl
sulfate (SDS). The CMC for SDS in pure water is approximately 8 mM [60].
Neutral molecules were not considered to be separable by CE until MEKC was
developed [57]. In CE, neutral molecules travel with the electroosmotic flow (EOF). In MEKC,
analytes partition between the pseudostationary phase and the separation buffer. Each analyte
partitions between the micelles and separation buffer differently, which is why neutral analytes
can be separated with MEKC [58, 59]. A schematic representation of MEKC is shown in Figure
1.12. Under electrophoresis conditions, anionic micelles are attracted to the anode; however, the
EOF overcomes the electrophoretic migration of the micelles, resulting in migration of the
micelles toward the cathode. Therefore, micelles migrate at a slower rate than the EOF [58, 59].
The use of MEKC for CE has been extensively reviewed by Terabe [58, 59].
Neutral analytes and analytes with similar charge-to-size ratios are often components of
enzyme-catalyzed reactions. Therefore, MEKC has been used in the development of enzyme
assays [61]. Most MEKC enzyme assays are off-column enzyme assays [61]. The enzyme is
added into a reaction vial containing the reaction components in a buffer that does not contain
the ionic surfactant. After incubation, the mixture is injected into the capillary, which is filled
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with the buffer containing the surfactant. This off-column method is used because SDS and other
common surfactants are known to denature proteins..

Injection

Electroosmotic flow
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molecule

Micelle

Analyte

Figure 1.12. Schematic representation of the mechanism of MEKC separations. An ionic
surfactant is added above its CMC to the running buffer for a CE separation, resulting in micelle
formation. The analytes partition between the pseudostationary phase and the separation buffer.
Although the micelles are attracted to the anode under electrophoresis conditions, the EOF
overcomes that attraction and the micelles migrate toward the cathode at a slower rate than the
EOF.
Many of the thousands of enzyme-catalyzed reactions occurring in a cell at any given
time involve nucleotides. In fact, nucleotides are found as intermediates in nearly all aspects of
metabolism [1]. For example, the nucleotide, adenosine 5ʹ-triphosphate (ATP), serves as an
energy carrier in numerous phosphate transfer enzyme-catalyzed reactions [1]. Because of the
many advantages of MEKC for CE separations, MEKC is very attractive for the analysis of
nucleotides and nucleosides, which can be difficult to separate using CE. Nucleosides are
neutral, making them difficult to analyze using traditional CE. The separation of nucleotides by
CE is difficult because some of them have poor peak shapes and similar charge-to-size ratios
[62-66].

23

Many researchers have worked to improve the separation of nucleosides and nucleotides
using MEKC. In 1989, Donlik et al. investigated several factors that affect the separation of
oligonucleotides [62]. In this study, it was determined that using SDS as an additive in the
background buffer enhanced the separation of polycytidines and eliminated the need for a coated
capillary. In 1996, Uhrova et al. investigated separations of mono, di, and triphosphates of
adenosine, guanosine, uridine and cytidine, and demonstrated enhancement of the separations
using SDS [66]. Kawaruma et al. demonstrated enhancement of a CE separation of adenine,
adenosine, and nucleotide isomers of adenosine using SDS in 1998 [64]. Also in 1998, Geldart
reviewed the challenges faced when separating nucleotides using CE and methods that have been
used to overcome those challenges, including MEKC [67].
Enzyme assays using MEKC with SDS have been developed for enzymes that catalyze
reactions involving nucleosides and nucleotides, such as adenosine deaminase [68] and
adenosine kinase [69]. In 2003, Carlucci et al. developed a CE methods for diagnosis and
monitoring of adenosine deaminase (ADA) deficiency [68]. This enzyme, found in almost all
human tissues, catalyzes the conversion of toxic adenosine (Ado) and 2'-deoxyadenosine (dAdo)
to nontoxic inosine and 2'-deoxyinosine. Deficiency of ADA leads to severe combined
immunodeficiency syndrome (SCID). As part of the method development, the authors
successfully demonstrated the separation of 11 purine compounds, including Ado, dAdo,
adenosine triphosphate (ATP), adenosine monophosphate (AMP), and dAMP, using SDS in the
separation buffer. In 2006, Iqbal et al. published work on the development of off-column and oncolumn CE methods for screening and characterizing adenosine kinase inhibitors and substrates
[69]. Adenosine kinase (AK) catalyzes the transfer of a phosphate group from ATP to adenosine,
which results in the product, AMP. The authors successfully demonstrated an off-column assay
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for AK using MEKC based on adding SDS into the separation buffer. In this assay, the AKcatalyzed phosphorylation of adenosine was successfully monitored, and adenosine derivatives
were investigated as alternative substrates for AK.
1.4.

Goals of this Research
The overall goal of the research presented in this dissertation was to develop new

methods for studying enzymes and enzyme inhibition using CE. Traditional enzyme assays have
significant limitations such as spectral interferences and indirect monitoring through the use of
coupling enzymes, which limit the range of enzymes that can be studied. When using CE for
enzyme assays, spectral interference and other limitations are minimized by separation of
substrates, products, inhibitors and sample matrix components. An important objective of this
research was to apply these newly developed CE assays to test botanical extracts and synthetic
compounds for inhibition of specific enzymes that could not be studied using other methods.
Chapter 2. A comparison of the photostability of fluorophores commonly used for
OGVCE was carried out as part of the overall goal of developing OGVCE-LIF enzyme assays.
The OGVCE-LIF technique is based on photobleaching a fluorescent compound as it is
continuously electrophoresed through a capillary. The initial goal of this project was to develop
an OGVCE assay for adenosine deaminase (ADA); however, the fluorescent ADA substrate
synthesized for the project (TNP-adenosine) was unusually photostable. As a result, the substrate
could not be photobleached, and the OGVCE assay for ADA could not be developed. However,
OGVCE-LIF was used to examine the photostability of fluorophores used for OGVCE, quantify
the photostability of TNP-adenosine relative to those fluorophores, and gain a better
understanding of the ideal properties of a dye for OGVCE assays.

25

Chapter 3. The main goal of this project was to develop an off-column CE assay for
measuring holo-ACC activity and inhibition. Using CE to study ACC has advantages over
previously developed ACC assays, which have limitations such as spectral interference, indirect
monitoring through the use of coupling enzymes, and the use of radioactivity. Two important
objectives for this project were to separate the two substrates and two products for the holo-ACC
reaction and simultaneously monitor both reactions catalyzed by the holo-ACC components, BC
and CT. Applying this CE assay to test known inhibitors of BC and CT for inhibition of holoACC inhibition was also an objective. Additional objectives for this project were to develop an
off-column assay for the BC component of ACC and optimize a previously reported CE assay
for the CT component.
Chapter 4. The goal of this project was to apply the CE-based enzyme assays developed
in Chapter 3 to screen botanical extracts for inhibition of holo-ACC, BC and CT in order to
identify natural products that inhibit ACC. A detailed literature search was used to identify
specific compounds found in the botanical extracts that did inhibit holo-ACC. Compounds
selected based on the literature search were also tested for inhibition of holo-ACC, BC and CT.
A compound found in cranberry extracts that showed inhibition of holo-ACC, BC and CT was
used as a model for ligand homology studies. Synthetic compounds identified from the ligand
homology studies were also tested for holo-ACC inhibition. Furthermore, detailed steady-state
kinetics studies were performed to determine patterns of inhibition for the compound that was
used as a model for the ligand homology studies.
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CHAPTER 2. COMPARISON OF FLUOROPHORES FOR OPTICALLY GATED
VACANCY CAPILLARY ELECTROPHORESIS AND THE UNUSUAL
PHOTOSTABILITY OF 2',3'-O-(2,4,6 TRINITROPHENYL) ADENOSINE
2.1.

Introduction
Capillary electrophoresis (CE) can be used for performing on-column enzyme assays and

for quantitative analysis of enzyme inhibition [39, 70]. Advantages provided by CE for enzyme
assays include simplicity, rapid analysis times and consumption of small amounts of enzyme per
assay [39]. Electrophoretically mediated microanalysis (EMMA) [71, 72] is a CE-based
technique for carrying out on-column reactions and is often used to perform enzyme inhibition
studies in capillaries and microchips [39, 70, 73]. Previously, Whisnant et al. developed a CEbased enzyme assay for alkaline phosphatase that combined continuous engagement EMMA and
transient engagement EMMA and utilized laser-induced fluorescence (LIF) detection [43, 44].
These enzyme inhibition studies provided useful information about the enzyme of interest;
however, the need for a fluorogenic substrate limits the range of enzymes that can be studied
using this technique. A fluorogenic substrate is a nonfluorescent substrate that yields a
fluorescent reaction product.
Capillary electrophoretic techniques using optically gated injections produce narrow
sample plugs for high-speed separations in capillaries and microchips [74-78] and have been
used for off-column enzyme assays in microchips [79, 80]. In these studies, the analytes of
interest were fluorescently labeled and continuously introduced into the microcolumn by
electrophoresis while being photobleached by a laser beam. The bleaching laser beam was
blocked briefly (gated) to inject a short zone of fluorescent sample. The fluorescent zones were
detected downstream by LIF, producing peaks in the resulting electropherograms. Optically
gated vacancy capillary electrophoresis (OGVCE) uses a similar approach and instrumentation
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[56, 81]. The fluorescent sample is continuously introduced into the microcolumn by
electrophoresis, but the bleaching beam is blocked by a shutter. The shutter is opened briefly,
which photobleaches the fluorescent species to produce a vacancy zone (negative peak). The
resulting electropherogram contains vacancy peaks for each fluorescent analyte.
Optically gated vacancy capillary electrophoresis has been used for electroosmotic flow
monitoring [55, 81, 82] and to perform separations in microchip devices [56]. Another potential
application for OGVCE is to perform on-column enzyme assays using fluorescent rather than
fluorogenic substrates. This would extend the range of enzymes that can be studied because
effective fluorescent substrates are much easier to design and synthesize compared to fluorogenic
substrates. For OGVCE-based enzyme assays, a fluorescent substrate requires several important
characteristics. First, the fluorescent substrate requires a high reaction rate in the enzymecatalyzed reaction of interest. Of course, the substrate should be highly fluorescent, and it should
be possible to excite the fluorophore at wavelengths accessible with common and inexpensive
laser sources. The fluorescent substrate and fluorescent reaction product also must be separable
by CE, preferably using simple separation conditions. Finally, it must be possible to photobleach
the fluorescent substrate and its reaction product at modest laser intensities. This last requirement
is, in a sense, unorthodox. Photostability of a fluorophore is highly desirable for most
applications.
In this chapter the photostability of several fluorophores used for OGVCE is examined.
The photostability of a potential fluorescent substrate for the enzyme, adenosine deaminase
(ADA), is studied also and compared to these fluorophores. The impacts of molar absorptivity
and electrophoretic migration rates on photobleaching for OGVCE are considered. These studies
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are important for determining which dyes perform best for OGVCE and for developing
fluorescent substrates for OGVCE-based enzyme assays.
2.2.

Materials and Methods

2.2.1. Chemicals
Adenosine, 2,4,6-trinitrobenzenesulfonic acid (TNBS) and fluorescein (sodium salt) were
purchased from Sigma-Aldrich (St. Louis, MO). Sodium hydroxide and sodium phosphate and
were purchased from Fisher Scientific (Fair Lawn, NJ). Calf intestinal adenosine deaminase was
purchased from Roche Diagnostics (Indianapolis, IN). Coumarin 334 and rhodamine B were
purchased from Acros Organics (Pittsburg, PA). Rhodamine 110 was purchased from Molecular
Probes (Eugene, OR). All solutions were prepared using ultrapure water (> 18 MΩ-cm;
ModuLab water system, United States Corp.; Palm Desert, CA).
2.2.2. Synthesis, storage and characterization of TNP-adenosine
Published procedures were used to synthesize TNP-adenosine [83, 84]. Briefly,
adenosine was reacted with TNBS overnight at a 10:1 molar ratio of adenosine to TNBS in
ultrapure water (adjusted to pH 10.5 with NaOH). After approximately 12 h, the reaction mixture
was acidified to pH 4.0, and TNP-adenosine precipitated. The product was washed with an icecold acetone-benzene mixture and filtered. Then the product was dissolved in water, and NaOH
was used to adjust the pH to neutral. The stock solution was stored at -20 ºC. An Econo-Pac 10
DG pre-packed polyacrylamide gel column from Bio-Rad Laboratories (Hercules, CA) was used
to purify the TNP-adenosine. The column was equilibrated with 1.0 mM sodium phosphate
buffer at pH 7.50, and a 3 mL sample in the same buffer was loaded onto the column. The same
phosphate buffer was used to elute the components, and 0.5 mL fractions were collected. The
TNP-adenosine was characterized using thin-layer chromatography, UV-VIS spectrophotometry
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(Cary 50 Bio UV/Vis Spectrophotometer) and CE with UV-Vis absorbance detection at 210 nm
as described in Section 2.3. Excitation-emission matrix spectra were collected for TNPadenosine on a Horiba Yvon Fluorolog 3 spectrofluorometer (Edison, NJ).
2.2.3. Capillary Electrophoresis
For all CE experiments, fused-silica capillary (50 µm i.d./360 µm o.d.) purchased from
Polymicro Technologies (Phoenix, AZ) was used. A MicroSolv window maker (Eatontown, NJ)
was used to remove the polyimide coating to make a window for photobleaching and detection.
Capillaries were rinsed with 1.0 M NaOH, ultrapure water and buffer for 10 min using a syringe
pump at the beginning of each day. A power supply (Spellman CZE 1000R) was used to apply
the potential for CE. Sodium phosphate buffer (20.0 mM, pH 7.55) was used for all experiments.
For CE with UV absorbance detection (Acutect 500 detector) as described previously [85]. All
buffers were filtered through a 0.2 µm nylon membrane (Whatman; Hillsboro, OR) prior to use
for CE.
2.2.4. Optically Gated Vacancy Capillary Electrophoresis with LIF Detection
The capillary used for OGVCE studies was 76.1 cm (total length) and 43.3 cm to the
window (effective length), and the applied potential was 369 V/cm (28.0 kV). The
instrumentation for the OGVCE experiments was similar to that reported previously [55, 86]. A
457.9, 488.0, or 514.5 nm line from a Coherent (Santa Clara, CA) 90C Series argon ion laser
passed through a cubic beamsplitter, and the beam was split for detection and photobleaching.
The bleaching beam passed through a computer-controlled shutter and was focused on the
capillary by a plano-convex lens. The power of the detection beam was reduced by a neutral
density filter to 4.0 mW, and the light was directed to the capillary by a dichroic mirror. The
light was focused onto the capillary by a 20× microscope objective, which also collected the
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fluorescence emission. The distance between the detection beam and bleaching beam positions
on the capillary was 470 μm, which was calculated as described previously [81]. The
fluorescence passed through the dichroic mirror and was spectrally filtered by a band-pass filter
before passing through an 800 µm pinhole for spatial filtering and being detected by a
photomultiplier tube (PMT, HC120-01, Hamamatsu, Bridgewater, NJ) at 850 V. Light from the
bleaching beam was collected by an optical fiber each time the shutter was opened and was also
detected by the PMT. This light resulted in a positive peak in the electropherograms and marked
the time at which the vacancy zones were created. A 250 Hz low-pass filter was used for filtering
the PMT output, and a data acquisition board (BNC-2080, National Instruments, Austin, TX)
was used for data collection at 200 Hz. Data collection and the shutter were controlled using a
LabVIEW 5.0 program written in-house.
2.2.5. OGVCE-LIF Flow Study
Three different flow rates, as well as several shutter opening times (25 ms to 2.5 s) were
used for OGVCE experiments with rhodamine 110. The excitation wavelength was 488.0 nm,
and the photobleaching beam and detection beam powers were 140.1 mW and 4.0 mW,
respectively. The distance between the photobleaching beam and the detection beam at the
capillary was increased to 1.0 cm from 470 μm for this study. The flow rate was changed by
decreasing the applied potential in 10.0 kV increments (369 V/cm, 237 V/cm and 105 V/cm).
Data were collected for 2 min for each combination of flow rate and shutter opening time.
2.2.6. Enzyme Assay
This assay was performed using the OGVCE instrument described in Section 2.4;
however, the photobleaching beam was blocked, and only LIF detection was performed using
excitation at 488 nm. The detection beam power was 4.0 mW, and emission was collected using
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a long-pass filter with a 550 nm cut-off. Adenosine deaminase (1 unit) was added to 150 µM
TNP-adenosine in 20.0 mM sodium phosphate, pH 7.55 (200 µL total reaction volume) to
initiate the enzyme-catalyzed reaction, and the mixture was immediately injected into the
capillary for 0.5 s. Injections and separations were performed electrokinetically at 439 V/cm
(25.0 kV). The injections were repeated every 3.0 min over a total of 40 min. For this study, the
capillary used was 57.0 cm (total length) and 36.0 cm to the detection window (effective length).
2.3.

Results and Discussion

2.3.1. TNP-Adenosine
Figure 2.1 shows the structure of TNP-adenosine, which was synthesized with the goal of
developing an enzyme assay for adenosine deaminase based on OGVCE. Fluorogenic substrates
are not available for adenosine deaminase, but TNP-adenosine, which is highly fluorescent, has
been reported to be a substrate for adenosine deaminase, forming the fluorescent product TNP-

Figure 2.1. Adenosine deaminase catalyzes the reaction of TNP-adenosine to form TNP-inosine.

inosine (Figure 2.1) [87]. Absorbance spectra and excitation-emission matrix spectra were
obtained for the synthesized TNP-adenosine. The visible absorbance maxima at 408 nm and 465
nm, were in accordance with literature reports [84, 87, 88]. The two excitation maxima at 408
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nm and 466 nm and the emission maximum at 550 nm were also in consistent with reported
values [87]. Finally, CE-LIF was used to confirm that ADA catalyzed the deamination of TNPadenosine to form TNP-inosine (Figure 2.2). Adenosine deaminase was added to the reaction
mixture, and injections were made from the reaction mixture at 3 min intervals. Immediately
after the addition of ADA, a large TNP adenosine peak was detected at 2.65 min, and a small
TNP-inosine peak was observed at 2.72 min. By 30 min nearly all of the TNP-adenosine had
reacted to form TNP-inosine.

Figure 2.2. Electropherograms for the adenosine deaminase assay. (A) Immediately after the
addition of adenosine deaminase (1 unit) to 150 µM TNP-adenosine, a large TNP adenosine peak
and a small TNP-inosine peak were observed. (B) At 30 min after addition of adenosine
deaminase, a large TNP-inosine peak was observed (product formation), and the TNP-adenosine
peak has decreased. Electrokinetic injections (0.5 s) and separations were performed at 25.0
kV(439 V/cm). The sample buffer and separation buffer were both 20.0 mM sodium phosphate,
pH 7.55. The electrophoretic current was 21.8 μA.

These experiments were repeated next with OGVCE instead of CE-LIF with an aim of
using the fluorescent substrate for development of an on-column ADA assay. Surprisingly, no
photobleaching was observed as shown in Figure 2.3. The power of the photobleaching beam
(138.0 mW) at 457.9 nm was substantially higher than that used other published OGVCE studies
at or near this wavelength (34.8-56.0 mW) [81, 82, 86, 89, 90] and is about 50% lower than the
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maximum power used for bleaching the laser dye, rhodamine B, at 514.5 nm in a previous study
(245 mW) [55]. This result suggests that TNP-adenosine is unusually resistant to photobleaching.
Varying the concentration of the TNP-adenosine from 15 to 300 M did not improve the ability
to photobleach it. Changing the pH of the phosphate buffer to 6.5 and 6.0 as well as attempts to
photobleach TNP-adenosine in a 50:50 mixture of ethanol and 20.0 mM sodium phosphate at pH
7.50 had no effect. This unexpected result for TNP-adenosine inspired a study to directly
compare the photostability of several fluorophores commonly used for OGVCE and to examine
related experimental issues that impact OGVCE and the extent of photobleaching.

Figure 2.3. Attempted photobleaching of 150.0 µM TNP-adenosine. The shutter was opened for
50 ms every 2.00 s as TNP-adenosine was continuously introduced into the capillary by
electrophoresis (369 V/cm). The power of the photobleaching was 138.0 mW, and the detection
beam was 4.0 mW (λ = 457.9 nm). The sample and separation buffer were 20.0 mM sodium
phosphate at pH 7.55.

2.3.2. Photostability of OGVCE dyes and TNP adenosine
A study was carried out to quantitatively compare the photobleaching of several dyes
commonly used for OGVCE: coumarin 334, fluorescein, rhodamine 110, and rhodamine B.
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Structures for these dyes are shown in Figure 2.4. The photobleaching of TNP-adenosine also
was compared to that for these four dyes. The neutral dyes, coumarin 334, rhodamine B and
rhodamine 110 have been used for continuous monitoring of electroosmotic flow dynamics in
capillaries [55, 81, 86, 89, 90] and in microfabricated devices [82]. Fluorescein has been used for
OGVCE separations in microfabricated devices [56].

Figure 2.4. Structures of the dyes that were used for the comparative photobleaching study.

Absorbance spectra were measured in order to account for differences in molar
absorptivity at the wavelength used for photobleaching of each dye. The concentrations of the
dyes were adjusted so that the absorbance of the solution containing each dye was the same at
their respective photobleaching/excitation wavelengths. The wavelengths, molar absorptivities
and concentrations are listed in Table 1. Each dye was continuously introduced into the capillary
by electrophoresis, and the dyes were photobleached every 1.00 s by opening the shutter
blocking the bleaching beam for 50 ms. The results of this study are summarized in Table 2.1.
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Table 2.1. Photobleaching percentages of dyes.
Dye

λ

ε

[C]
(μM)

TNP-adenosine

457.9

12,700

6.15

Coumarin 334

457.9

49,500

1.58

Fluorescein

488.0

52,100

1.55

Rhodamine
110
Rhodamine B

488.0

14,600

5.40

514.5

19,300

4.00

Bleaching
Power
(mW)
138.0

140.2
35.8
140.2
34.0
140.2
121.6
140.5
91.5

Bleaching
(%)


83
44
96
83
37
33
6
4

The extent of photobleaching is reported as the photobleaching percentage, which is
calculated according to Equation 2.1, where SV, is the vacancy signal, which is the minimum
[

]

(2.1)

fluorescence of the negative peak resulting from photobleaching, SF is the fluorescence signal
when the dye is not photobleached (shutter closed), and SB is the baseline signal in the absence of
the fluorophore. These terms are shown graphically in Figure 2.5.
Photobleaching of each dye was determined at a bleaching beam power near 140 mW,
which was the maximum that could be used with this system at all of the wavelengths of interest.
Representative electropherograms (coumarin 334 and rhodamine B) are shown in Figure 2.6.
Fluorescein was the most susceptible to photobleaching (96%), followed by coumarin 334
(83%), rhodamine 110 (37%) and rhodamine B (6%). As discussed in Section 3.1 and shown in
Figure 2.3, TNP-adenosine did not photobleach significantly at any bleaching power tested.
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Figure 2.5. Electropherogram with photobleaching percentage variables labeled. The equation
[(SF - SV) /(SF - SB)] × 100%, is used to determine the photobleaching percentage. The average
fluorescence signal in the presence of the fluorophore is SF, and the vacancy signal, SV, is the
minimum fluorescence of the negative peak resulting from photobleaching. The average baseline
signal in the absence of fluorophore is SB. This electropherogram is from rhodamine 110 (5.40
µM) photobleached with a 121.6 mW photobleaching beam power where the photobleaching
percentage was 33%. The shutter was opened for 50 ms every 1.00 s. The excitation wavelength
was 488.0 nm. The detection beam was 4.0 mW. Electrophoresis was performed at 28.0 kV (369
V/cm). The separation buffer was 20.0 mM sodium phosphate at pH 7.55.

Figure 2.6. Photobleaching of (A) 1.58 µM coumarin 334 and (B) 4.00 µM rhodamine B with a
140 mW photobleaching beam power. The shutter was opened for 50 ms every 1.00 s. The
excitation wavelengths were (A) 457.9 nm and (B) 514.5 nm. All other conditions are the same
as in Figure 2.3. The distance between the detection beam and bleaching beam positions on the
capillary was 470 μm.
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As indicated in Table 1, the photobleaching power also was attenuated from 140 mW
according to the molar absorptivity for each dye relative to that for TNP-adenosine. Under these
conditions, the total absorbances of the solutions were different, but each dye molecule absorbed
the same number of photons as TNP-adenosine at 138.0 mW. Figure 2.7 shows representative
electropherograms for rhodamine 110 and fluorescein. The order of relative photobleaching did
not change with TNP-adenosine (no photobleaching) and rhodamine B (4%) being the most
resistant to photobleaching. Fluorescein was still 83% photobleached at only 34.0 mW, while
coumarin 334 photobleaching dropped by almost a factor of two (83% to 44%) when the
bleaching beam power was decreased to 35.8 mW. For rhodamine 110, the decrease in
photobleaching (37% to 33%) was approximately proportional to the decrease in bleaching beam
power (140.2 to 121.6 mW).

Figure 2.7. Electropherograms for photobleaching at reduced photobleaching power. (A)
Rhodamine 110 (5.40 µM) was photobleached at 121.6 mW. (B) Fluorescein (1.55 µM) was
photobleached at 34.0 mW. The shutter was opened for 50 ms every 1.00 s. The excitation
wavelength was 488.0 nm. All other conditions were the same as in Figure 2.3.

Previously, the photobleaching properties of rhodamine B and fluorescein were
investigated as part of studies of the photobleaching of organic laser dyes at micromolar
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concentrations in methanol and in static solutions [91, 92]. In both studies, the photobleaching
properties of the dyes were compared and contrasted to provide information about their use as
laser dyes. For that application high photostability is beneficial. In one study, it was determined
that the quantum efficiency of rhodamine B was 15 times smaller than that for fluorescein under
pulsed photobleaching conditions [91]. In the other study, fluorescein was found to photobleach
more readily than rhodamine B under continuous illumination at 514.5 nm, while fluorescein and
rhodamine B had the same photobleaching properties under continuous illumination at 359.0 nm
[92]. In studies conducted by Saylor, the photostability of fluorescein was investigated for fluid
mechanics applications [93]. It was found that fluorescein was photobleached after only 1 ms of
laser irradiation, which was not desirable for fluid mechanics experiments [93]. Hinkeldey et al.
investigated the photostability of fluorescein for use in single-molecule applications requiring
high photostability and concluded that fluorescein dyes were less photostable than
borondipyrromethene (BODIPY) dyes [94]. The photobleaching properties of rhodamine B and
fluorescein have also been investigated using independently using conventional optical gating
[75] and OGVCE [55]. Tao et al. compared the photostability of fluorescein and
orthophthalaldehyde/β-mercaptoethanol (OPA-βME) using conventional optical gating, and they
found that fluorescein is substantially more stable than OPA-βME [75]. In a study conducted by
Pittman et al., it was found that rhodamine B only photobleached 30% when using a 230 mW
photobleaching beam power (λ = 514.5 nm) and a shutter opening time of 75 ms while
rhodamine B was electrophoresed at a field strength of 138 V/cm [55]. A detailed discussion
directly comparing the photobleaching properties of common OGVCE dyes at typical conditions
for this method has not been reported.
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2.3.3. Migration Rate Study
The migration rate of a fluorophore should affect the photobleaching of a dye by
OGVCE. Consider a dye molecule passing through the bleaching beam in a capillary. The
migration rate of the molecule will affect the total number of photons the molecule is exposed to
as it passes through the bleaching beam. Unless the molecules are all photobleached rapidly
before they have passed through the bleaching beam, their migration rate will impact the total
number of photons they are exposed to and, thus, the extent of photobleaching. Sugarman and
Prud’homme examined the impact of photobleaching of fluorescein on the response of a laserinduced fluorescence detector for pressure-driven flow in capillaries [95]. In the study presented
here, negatively charged fluorescein migrates more slowly through the bleaching beam compared
to the neutral dyes (rhodamine B, rhodamine 110, and coumarin 334. The photobleaching of
fluorescein and rhodamine 110 at different migration rates was investigated here in order to
determine the extent to which migration speed impacted the photobleaching results for these
dyes.
Panel A of Figure 2.8 shows the photobleaching of 5.40 µM rhodamine 110 at decreasing
flow rates (EOF) when the shutter was opened every 15.00 s for 50 ms. The flow rate was
changed by decreasing the applied voltage by 10.0 kV increments (369 V/cm, 237 V/cm, and
105 V/cm) every 2 min over a 6 min time frame. As seen in panel A of Figure 2.8, the
photobleaching percentage actually decreased as the flow rate decreased. This unanticipated
result occurred due to band broadening caused by molecular diffusion as the narrow vacancy
zones travelled 1.0 cm to the detection beam spot [55, 82]. The experiment was repeated (Figure
2.8, panel B), but the shutter opening time was increased 20 fold (1.00 s instead of 50 ms),
producing broader vacancy zones. The depth of these broader zones was not reduced
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significantly by zone broadening, and the bleaching percentage increased with decreasing flow
rate as expected. Similar experiments were performed with fluorescein (data not shown).
Because fluorescein bleaches much more readily than the other dyes studied (Table 2.1), the
changes in photobleaching percentage at different flow rates were minimal for these
experimental conditions. Tao et al. studied the effect of migration rate for optically gated
injections of amino acids derivatized by OPA-βME [75]. In those studies, the photobleaching
beam was gated in order to form a zone of unbleached analytes to be separated and detected as
peaks in the resulting electropherogram. They also concluded that longitudinal diffusion led to
increased band broadening for slower migrating analytes as they traveled from the injection spot
to the detection spot inside the capillary. Similar observations were made by Moore and
Jorgenson for optically gated injections of compounds labeled with fluorescein isothiocyanate
(FITC) [96].

Figure 2.8. Photobleaching of 5.40 µM rhodamine 110 at decreasing flow rates when the shutter
was opened every 15 s for (A) 50 ms and (B) 1.00 s. The flow was changed by decreasing the
applied voltage to the capillary by 10.0 kV (369 V/cm, 237 V/cm, and 105 V/cm) every 2 min
over a 6 min time period. The excitation wavelength was 488.0 nm. All other conditions are the
same as in Figure 2.3.
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2.4.

Conclusions
The relative photostability of four fluorophores commonly used for OGVCE was studied

quantitatively and compared to the photostability of TNP-adenosine. These studies will be
beneficial for determining which dyes will perform best OGVCE studies and for developing
fluorescent substrates for OGVCE-based enzyme assays. Fluorescein was found to be most
susceptible to photobleaching, followed by coumarin 334 and rhodamine 110. Rhodamine B was
the most photostable common OGVCE dye tested. The fluorescent substrate for adenosine
deaminase, TNP-adenosine, didn’t photobleach significantly under any conditions tested, making
it unsuitable for development of an OGVCE enzyme assay. It was shown that rhodamine 110
photobleaching increased when the flow rate decreased in the absence of significant band
broadening. High fluorescence for LIF detection and ease of photobleaching are the two most
important properties of a dye for OGVCE, but other characteristics are also important. For
example, a net neutral charge is essential for use of a dye for EOF measurements, and minimal
adsorption to the capillary or microchip wall is important. For an OGVCE enzyme assay, the
fluorescent substrate and product should be easily separable. Finally the wavelength needed for
photobleaching and excitation ideally will match an inexpensive laser source.
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CHAPTER 3. A CAPILLARY ELECTROPHORETIC ASSAY FOR ACETYL COA
CARBOXYLASE1
The research presented in this chapter is based on a recent publication and was
reproduced with permission from: Bryant, S. K., Waldrop, G. L., Gilman, S. D. A Capillary
Electrophoretic Assay for Acetyl CoA Carboxylase, Analytical Biochemistry, 2013, 437 (1), 3238.
3.1.

Introduction
Acetyl coenzyme A carboxylase (ACC) catalyzes the first committed and rate-limiting

step in fatty acid biosynthesis in all bacteria, plants, and animals. The biotin-dependent
carboxylation of acetyl coenzyme A (CoA) to form malonyl-CoA is carried out in two halfreactions (Figure 3.1) [97]. In the first half-reaction, biotin carboxylase (BC) catalyzes the
conversion of adenosine triphosphate (ATP) to adenosine diphosphate (ADP), and the
carboxylation of biotin, which in vivo is covalently attached to biotin carboxyl carrier protein
(BCCP). In the second half-reaction, carboxyltransferase (CT) catalyzes the transfer of the
carboxyl group on biotin to acetyl-CoA to form malonyl-CoA. In bacteria, BC, CT, and BCCP
are separate proteins, and BC and CT retain their activity using free biotin in place of BCCP
[97]. In eukaryotes, these three components of ACC are combined in one polypeptide [97].
Acetyl coenzyme A carboxylase is a target for the development of antibiotics [98, 99], herbicides
[100], and therapeutic agents for metabolic syndrome (including obesity and type 2 diabetes)
[101-105] and cancer [106, 107]. Thus, effective assays to measure the inhibition of ACC are
desirable.

1

This chapter previously appeared as Bryant, S. K., Waldrop, G. L., Gilman, S. D. A Capillary
Electrophoretic Assay for Acetyl CoA Carboxylase, Analytical Biochemistry, 2013, 437 (1), 3238. It is reprinted with permission from Elsevier.
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Several assays have been developed to monitor the activity of isolated bacterial BC and
CT, as well as holo-ACC from either bacterial or eukaryotic sources. Hereafter, holo-ACC will
refer to the case when all three bacterial proteins, BC, CT, and BCCP are present in solution.
Early studies of E. coli ACC utilized a radiolabeled bicarbonate fixation assay for determining
the activity of holo-ACC and isolated BC [108]. Moreover, BC was also assayed with an
enzyme-coupled assay, where ADP formation was monitored spectrophotometrically at 340 nm
via NADH oxidation [108]. The enzymatic activity of isolated bacterial CT was commonly
assayed in the reverse (nonphysiological) direction using either a radioactivity assay that
measured the biotin-dependent decarboxylation of radiolabeled malonyl-CoA, or where acetylCoA production was coupled to the citrate synthase-malate dehydrogenase reaction and NAD+
reduction was monitored spectrophotometrically at 340 nm [108]. More recently, Kroeger et al.
developed an NADPH based spectrophotometric assay for holo-ACC, where malonyl-CoA
reductase was used to catalyze the NADPH-dependent reduction of the product, malonyl-CoA
[109]. In addition, Alves et al. reported an assay for holo-ACC based on HPLC with tandem
mass spectrometry (LC-MS/MS), where the enzyme and substrates were incubated for 3 hr at
room temperature and malonyl-CoA formation was monitored [110].

Figure 3.1. Acetyl-CoA carboxylase reaction scheme
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Several of these assays for ACC have been adapted and optimized for high-throughput
screening. Harwood et al. [103] developed a plate reader-based high-throughput screening assay
for mammalian ACC based on the radiolabeled bicarbonate fixation assay of Guchhait et al.
[108]. Subsequently, Santoro et al. developed a plate reader-based high-throughput screening
assay for bacterial CT in the nonphysiological direction where citrate synthase was coupled to
the production of acetyl-CoA and the product CoA was detected with DTNB (Ellman’s Reagent)
[111]. Soriano et al. developed a plate reader-based high-throughput assay for ACC that
involved the use of 32P-labeled ATP [112]. Seethala et al. developed a high-throughput assay for
mammalian ACC where radiolabeled acetyl-CoA was used in an ACC/fatty acid synthase
coupled assay and radiolabeled palmitic acid was detected [113]. Lui et al. reported two highthroughput assays for mammalian ACC where amplex red was used with two coupled enzymecatalyzed reactions to detect phosphate by fluorescence or fluorescence polarization was used to
monitor fluorescently labeled ADP binding to an anti-ADP antibody [114]. Chung et al. reported
a high-throughput fluorescence assay where mammalian ACC activity was coupled to fatty acid
synthase activity [115]. Recently Alves et al. developed a plate reader luminescence-based assay
for assaying holo-ACC that monitored the depletion of ATP [110].
The previously developed assays each have significant limitations for screening of ACC
inhibitors. The assays based on radiolabelling can be expensive and complex in practice due to
health, waste and regulatory issues. The method based on LC-MS/MS provides comparable
selectivity without the health and regulatory issues associated with radiolabelling, but it relies on
complex methodology and expensive instrumentation. Assays based on enzyme-coupled
reactions are inherently indirect and more susceptible to false positives for inhibition studies.
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Additionally, spectrophotometric assays based on UV absorbance or fluorescence with UV
excitation are prone to spectral interference by inhibitors and biological sample matrices.
Recently, we developed a simple capillary electrophoresis-based assay for the CT
component of ACC using UV absorbance detection [116]. This method was developed to
overcome spectral interference for particular inhibitors and botanical extracts that could not be
assayed using the enzyme-coupled spectrophotometric method employed for the rest of the study
[117]. Capillary electrophoresis (CE) has been used for a wide array of applications, and CE has
several advantages including high separation efficiency, simplicity, small sample volume (nL)
and rapid analysis times [33]. It has been demonstrated that CE can be used effectively for
performing quantitative enzyme assays and studying enzyme inhibition [38, 39]. Because CE is
an electrophoretic separation technique, spectral interference is reduced by separation of
substrates, products, inhibitors and sample matrix components.
Herein, we report an off-column capillary electrophoretic assay to measure holo-ACC
activity and inhibition that allows for simultaneous monitoring of the BC and CT catalyzed
reactions. To our knowledge, this is the first report of simultaneous, direct monitoring of ATP
and acetyl-CoA depletion, and ADP and malonyl-CoA production for determination of holoACC activity. Also, the CE assay for CT [116] has been optimized, and a CE assay for the BC
component of ACC has been developed.
3.2.

Materials and Methods

3.2.1. Reagents and assay solutions
Acetyl coenzyme A, malonyl-CoA, ATP, ADP, biocytin, dimethyl sulfoxide, potassium
phosphate monobasic, potassium bicarbonate, benzoic acid, magnesium chloride and sodium
dodecyl sulfate were purchased from Sigma-Aldrich (St. Louis, MO). (2E,4E,6E)-N-((S)-3-(((S)-
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3-methyl-1-((3R,4S)-4-methyl-2,5-dioxopyrrolidin-3-yl)-1-oxobutan-2-yl)amino)-3-oxo-1phenylpropyl)octa-2,4,6-trienamide (andrimid) was a gift from Pfizer. 2-amino-N,Ndibenzyloxazole-5-carboxamide was synthesized according to the protocol published by
Mochalkin et al. [99]. Tris(hydroxymethyl)aminomethane (tris) was purchased from Acros
Organics (Morris Plains, NJ). N-2-hydroxyethylpiperazine-N′-2-ethanesulfonic acid (HEPES)
was purchased from EMD Millipore (Billerica, MA), and sodium phosphate and sodium
hydroxide were purchased from Fisher Scientific (Fair Lawn, NJ). Biotin carboxylase and
carboxyltransferase from Escherichia coli were purified as described previously [117]. Biotin
carboxyl carrier protein was a gift from Pfizer. All solutions were prepared using ultrapure water
(> 18 MΩcm, ModuLab water system, United States Filter Corp., Palm Desert, CA). All buffers
were filtered through a 0.2 m nylon membrane (Whatman; Hillsboro, OR) prior to use for CE.
3.2.2. Capillary electrophoretic enzyme assays
All assays were performed using a P/ACE MDQ system with UV absorbance detection
(photodiode array detector) from Beckman Coulter, Inc. (Brea, CA). The data were collected and
analyzed using 32 Karat 5.0 software from Beckman Coulter, Inc. Fused-silica capillary (50-µm
i.d./360-µm o.d.) was purchased from Polymicro Technologies (Phoenix, AZ) and cut to a total
length of 59.8 cm. The polyimide coating was removed using a MicroSolv CE window maker
(Eatontown, NJ) to make a 3-mm detection window at 49.8 cm (effective length). The capillary
was rinsed with 1.0 M NaOH, ultrapure water and 20.0 mM sodium phosphate buffer at pH 7.55
for 10.0 min at 20 psi for conditioning at the beginning of each day. All reaction vials were held
at 25 ºC and the capillary was held at 25 ºC. All injections were performed hydrodynamically at
0.5 psi for 10.0 s. All separations were performed using 30.0 kV (508 V/cm). All
electropherograms were plotted with absorbance at 256 nm.
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All enzyme assay reaction samples were prepared in 5.00 mM potassium phosphate
buffer at pH 7.55 (reaction buffer). The capillary was rinsed with the separation buffer for 30.0 s
at 20 psi prior to each injection. All enzyme reactions were performed off-column in a 1.5 mL
glass Beckman CE vial in a 1.0 mL total volume.
3.2.3. Carboxyltransferase CE assay
The assay mixture contained 250.0 μM malonyl-CoA and 4.00 mM biocytin in the
reaction buffer. To initiate the reaction, CT was added to the reaction mixture to a final
concentration of 10.0 µg/mL. The assay mixture was injected for CE analysis after 1.0 min and
again after 9.5 min. The CT assay was carried out using 5.0 mM potassium phosphate buffer at
pH 7.55, which was also used for the separation buffer.
3.2.4. Biotin carboxylase CE assay
The BC assay mixture contained 50.0 μM ATP, 2.5 mM MgCl2, 50.0 mM biotin, 5.0 mM
potassium bicarbonate and 200 µM benzoic acid (used as an internal standard) in the reaction
buffer. To initiate the reaction, BC was added to the reaction mixture to a final concentration of
20.0 µg/mL, and the assay mixture was injected for CE analysis after 1.0 min and again after
12.0 min. The separation buffer contained 10.0 mM sodium phosphate and 20.0 mM sodium
dodecyl sulfate at pH 7.55.
3.2.5. Holo-ACC CE assay
The holo-ACC assay mixture contained 25.0 µM ATP, 50.0 µM acetyl-CoA, 2.50 mM
MgCl2, 2.0 µM BCCP and 5.0 mM potassium bicarbonate in the reaction buffer. The reaction
was initiated by adding BC and CT to a final concentration of 10.0 µg/mL in the assay mixture.
The assay mixture was injected for CE analysis after 1.0 min and again after 9.5 min. 2-aminoN,N-dibenzyloxazole-5-carboxamide (212 μM) or andrimid (30.0 µM) was used for studying
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inhibition of holo-ACC. Both inhibitors were dissolved in DMSO, and the assay mixtures
contained 0.3% DMSO for those experiments. During preliminary studies, it was concluded that
DMSO did not interfere with the enzymatic reaction or the separation of the substrates, products,
and inhibitors. After adding BC (10.0 µg/mL) and CT (10.0 µg/mL) to the assay mixture
containing inhibitor, the mixture was injected for CE analysis at 1.0 min and at 11.5 min. The
separation buffer for all assays contained 10.0 mM sodium phosphate and 20.0 mM sodium
dodecyl sulfate at pH 7.55.
3.3.

Results and Discussion

3.3.1. Optimized CE assay for carboxyltransferase
We previously developed an off-column capillary electrophoretic assay for the CT
component of ACC using UV absorbance detection [116]. The assay used in that study was
functional but had not been optimized. The buffers for the sample (enzyme reaction mixture) and
CE separation were substantially different in terms of composition and conductivity, which can
lead to relatively poor CE peak shapes and separations [86, 118, 119]. The assay for CT was
optimized primarily by matching the separation and enzyme reaction buffers. Both the enzyme
reaction and separation buffers contained 5.0 mM potassium phosphate at pH 7.55. The reaction
was monitored in the nonphysiological direction (malonyl-CoA reacts to form acetyl-CoA), and
the reaction mixture contained the substrates, malonyl-CoA (250 µM) and biocytin (4.00 mM).
Because the Km of malonyl-CoA for CT is 100 M [117], 250 µM malonyl-CoA was used. In
bacteria, CT retains its activity using free biotin in place of the BCCP [97]. Biocytin, a more
reactive analog of biotin where lysine is attached to the valeric acid carboxyl group (Figure 3.2),
is commonly used when running the CT assay in the nonphysiological direction [117].
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Figure 3.2. Structures of the compounds that were used to perform holo-ACC, CT, and BC
assays.
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Panel A of Figure 3.3 shows an electropherogram for 250 µM malonyl-CoA and 4.00 mM
biocytin just prior to the addition of CT to initiate the reaction. A large malonyl-CoA peak is
evident at 6.6 min. Panel B of Figure 3.3 shows an electropherogram 9.5 min after the addition
of CT (final concentration, 10 µg/mL). A large acetyl-CoA peak with a migration time of 5.3
min is observed, and a very small malonyl-CoA peak is observed, indicating that the reaction
was near completion. The peak shapes and separation of malonyl-CoA and acetyl-CoA were
significantly improved relative to previous work as a result of optimizing the assay by better
matching the sample buffer and separation buffer [116].

Figure 3.3. Electropherograms for the CT assay. (A) The assay reaction mixture contained 250
μM malonyl-CoA and 4.00 mM biocytin prior to addition of the enzyme. (B) At 9.5 min after
addition of CT, a large acetyl-CoA peak was observed (product formation), and the malonyl-CoA
peak had decreased. The sample buffer and separation buffer were both 5.0 mM potassium
phosphate at pH 7.55. All injections were made at 0.5 psi for 10.0 s. The field strength for CE was
508 V/cm with a current of 11.1 µA.

3.3.2. Development of a CE assay for biotin carboxylase
An off-column CE assay for BC also was developed. Although ACC normally functions
with both enzymes as holo-ACC, it is important to have assays for BC alone and CT alone. For
example, these assays can be used to determine which part of ACC is being inhibited by a
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molecule that inhibits holo-ACC. The assay reaction mixture contained ATP (50 μM) and biotin
(50 mM), as well as 2.5 mM MgCl2, 5.0 mM potassium bicarbonate and 200 µM benzoic acid
(internal standard). The Km for ATP in isolated BC is 80 µM [120], and an ATP concentration
(50 M) was selected close to the Km that resulted in a substrate peak with an adequate signal-tonoise ratio for the assay. Biotin is needed in the reaction mixture because BC catalyzes the
carboxylation of biotin. Bicarbonate is the source of CO2 for the carboxylation reaction, while
MgCl2 is needed because BC activity requires two equivalents of the metal ion. One equivalent is
chelated to ATP such that the metal nucleotide chelate is the substrate for BC, while the other
metal ion binds in the active site and participates in catalysis [121]. Panel A of Figure 3.4 shows
an electropherogram for 50 μM ATP just prior to the addition of enzyme to initiate the reaction.

Figure 3.4. Electropherograms for the biotin carboxylase assay. (A) The reaction mixture
contained 50 μM ATP, 2.5 mM MgCl2, 50 mM biotin, 5.0 mM potassium bicarbonate and 200 µM
benzoic acid prior to addition of the enzyme. (B) At 12.0 min after addition of BC, an ADP peak is
observed (product formation). The sample buffer was 5.0 mM potassium phosphate at pH 7.55,
and the separation buffer was 10.0 mM sodium phosphate at pH 7.55 with 20.0 mM SDS. All
injections were made at 0.5 psi for 10.0 s. The field strength for CE was 508 V/cm with a current
of 26.8 µA.
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Panel B of Figure 3.4 shows an electropherogram at 12.0 min after the addition of BC (final BC
concentration of 20 µg/mL). An ADP peak with a migration time of 7.5 min is observed,
indicating that the reaction is proceeding. The development of the separation conditions used for
this assay is described in Section 3.3.3.
3.3.3. Development of a CE assay for holo-ACC
The first step in the development of a CE assay for holo-ACC assay was to separate all of
the substrates (ATP, acetyl-CoA) and products (ADP, malonyl-CoA) that have significant
absorbance at 256 nm. A number of separation conditions were tested with a goal of identifying
a buffer system that would allow resolution of the four molecules and also would be appropriate
for the enzyme-catalyzed reactions. Because ACC functions well from pH 7.0 and 8.0, buffers
were tested that could be used in that pH range. When using HEPES buffer alone (10.0 and 20.0
mM) at pH 7.55 or HEPES buffer with 2.0 mM KCl at pH 7.55, the 4 peaks were not fully
resolved and the ATP peak width would range from 15 to 30 s. The separation was also
attempted using 20.0 mM tris at pH 8.00, but similar results were obtained. Sodium dodecyl
sulfate (SDS) was added to the separation buffer to improve the separation based on previous
reports of separations of ATP and ADP for off-column enzyme assays and other applications
[62, 63, 67-69]; however, the 4 peaks were not resolved using 20.0 mM HEPES with 15.0 mM
SDS at pH 7.55. Attempts were made to add SDS to 20.0 mM HEPES buffer (pH 7.55)
containing 2.0 mM KCl since the reaction buffer contained KCl, but the SDS precipitated out of
solution upon KCl addition. Next, 10.0 mM sodium phosphate at pH 7.55 was used for the
separation, but only 2 of the 4 peaks were resolved (Figure 3.5, panel A). Finally, resolution of
all 4 peaks was achieved using 10.0 mM sodium phosphate with 20.0 mM SDS at pH 7.55, as
shown in panel B of Figure 3.5.
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Figure 3.5. Electropherograms for separation of holo-ACC assay components. (A) Separation of
a mixture of acetyl-CoA, malonyl-CoA, ATP and ADP (25 µM each). The sample and separation
buffer was 10.0 mM sodium phosphate at pH 7.55. (B) The same sample separated using 10.0
mM sodium phosphate, pH 7.55 with 20.0 mM SDS as the separation buffer. All injections were
made at 0.5 psi for 10.0 s. The field strength was 508 V/cm with a current of 19.0 μA for (A) and
25.2 μA for (B).

The substrate concentrations used for the holo-ACC assay were different than the
concentrations used for assaying the individual components, BC and CT. The Km for ATP in
holo-ACC is 4 µM (T.C. Broussard and G.L. Waldrop, unpublished observations); however, a
substantially higher ATP concentration of 25 μM was required to obtain an adequate signal-tonoise ratio. While the Km for acetyl-CoA in holo-ACC is 0.5 mM, the concentration of acetylCoA used in the CE assay was only 50 M because the ATP concentration was only 25 µM. The
second half-reaction is limited by the amount of product produced in the first half-reaction
(Figure 3.1), and higher concentrations of acetyl-CoA would not result in more malonyl-CoA
production because ATP is the limiting reagent in this two-step reaction. Additionally, the
reaction solution contained 2.5 mM MgCl2, 2.0 µM BCCP, and 5.0 mM potassium bicarbonate,
but it did not contain SDS, which would denature the proteins. Panel A of Figure 3.6 shows an
electropherogram for 25 µM ATP and 50 µM acetyl-CoA just prior to the addition of enzyme to
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initiate the reaction. Panel B of Figure 3.6 shows an electropherogram 9.5 min after the addition
of BC and CT (final concentration of 10 µg/mL each). An ADP peak is observed with a
migration time of 6.2 min, and a malonyl-CoA peak is observed with a migration time of 7.3
min, indicating that the reaction is proceeding. Furthermore, the necessary differences between
the reaction solution and the separation buffer did not significantly degrade the separation as
indicated in panel B of Figure 3.6.

Figure 3.6. Electropherograms for the holo-ACC assay. (A) The reaction solution contained 25
μM ATP, 50 μM acetyl-CoA, 2.5 mM MgCl2, 2.0 μM BCCP, and 5.0 mM potassium bicarbonate
prior to the addition of 10.0 µg/mL of CT and 10.0 µg/mL of BC to initiate the reaction. (B) At
9.5 min after initiation of the reaction (addition of CT and BC), ADP and malonyl-CoA peaks
were observed (product formation) and ATP and acetyl-CoA had decreased. The sample buffer
was 5.0 mM potassium phosphate at pH 7.55 and the separation buffer was 10.0 mM sodium
phosphate at pH 7.55 with 20.0 mM SDS. All injections were made at 0.5 psi for 10.0 s. The field
strength for CE was 508 V/cm with a current of 24.6 μA.

Two well documented inhibitors of BC and CT were used to determine the effectiveness
of the new CE assay for detecting inhibition of holo-ACC. The BC inhibitor used as a positive
control was 2-amino-N,N-dibenzyloxazole-5-carboxamide (Figure 3.2), which was developed by
Pfizer as an antibiotic [99]. This inhibitor concentration was tested first at 212 M, which is well

55

above the IC50 value of 0.125 M reported by Mochalkin et al. [99]. The inhibitor has a strong
absorbance at 256 nm, so 3 peaks are observed instead of the usual 2 for ATP and acetyl-CoA
prior to the addition of the two enzymes (Figure 3.7, panel A). It is important to note the strong
absorbance of 2-amino-N,N-dibenzyloxazole-5-carboxamide. If the inhibitor, substrate, and
product absorb at the same wavelength, the inhibitor would significantly interfere with
traditional cuvette-based or plate reader-based assays due to spectral interference. Because CE is
a separation technique, the inhibitor can be physically separated from the substrates and
products, eliminating spectral interference. After adding CT and BC to the reaction mixture and
allowing the reaction to proceed for 11.5 min, no product formation was observed, indicating
strong inhibition (Figure 3.7, panel B).

Figure 3.7. Electropherograms for the holo-ACC assay with 2-amino-N,N-dibenzyloxazole-5carboxamide (A-O). (A) The reaction mixture contained 212 μM 2-amino-N,Ndibenzyloxazole-5-carboxamide, 25 μM ATP, 50 μM acetyl-CoA, 2.5 mM MgCl2, 2.0 μM
BCCP, and 5.0 mM potassium bicarbonate prior to the addition of addition of 10.0 µg/mL of
CT and 10.0 µg/mL of BC to initiate the reaction. (B) At 11.5 min after initiation of the reaction
there was no product formation observed. All other conditions are the same as in Figure 3.6.
This inhibitor was also tested near the IC50 value at 0.20 M using the same reaction time (11.5
min) and conditions. Product formation was observed at this concentration, but it was
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significantly reduced compared to experiments without inhibitor. The ratio of peak areas for
ADP/ATP decreased from 1.2 (no inhibitor) to 0.57 (0.20 M 2-amino-N,N-dibenzyloxazole-5carboxamide). Corresponding ratios for malonyl-CoA/acetyl-CoA were 0.79 (no inhibitor) and
0.55 (0.20 M inhibitor). The IC50 was not determined here, but other studies have shown that
this is possible using off-column CE assays [39].
Inhibition of holo-ACC using a known CT inhibitor, andrimid, also was studied [98].
Andrimid (Figure 3.2) is a natural product isolated from a marine isolate of Pseudomonas
fluorescens that exhibits broad spectrum antibacterial activity [122]. A concentration of 30 µM
was used, which is well above the IC50 value of 13 nM, reported by Freiberg et al. [98].
Electropherograms before addition of CT and BC and at 11.5 min after initiation of the reaction
are shown in Figure 3.8. No product formation was observed. Unlike the BC inhibitor, andrimid
does not absorb strongly at 256 nm. These results with inhibitors of both BC and CT are
important because they show the assay can detect inhibition of bacterial holo-ACC, regardless of
which half reaction the inhibitor is targeting.

Figure 3.8. Electropherograms for the holo-ACC assay with andrimid. (A) The reaction mixture
contained 30 μM andrimid, 25 μM ATP, 50 μM acetyl-CoA, 2.5 mM MgCl2, 2.0 μM BCCP, and
5.0 mM potassium bicarbonate prior to the addition of 10.0 µg/mL of CT and 10.0 µg/mL and
10.0 µg/mL of BC to initiate the reaction. (B) At 11.5 min after initiation of the reaction, no
production formation was observed. All other conditions are the same as in Figure 3.6.
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3.4.

Conclusions
The first off-column capillary electrophoretic assay for holo-ACC that allows for

simultaneous monitoring of the holo-ACC components, BC and CT, is described. For this assay,
acetyl-CoA, malonyl-CoA, ATP, and ADP were separated by CE. The assay allows for
simultaneous screening of inhibitors against BC and CT by directly monitoring the depletion of
ATP and acetyl-CoA, and the concomitant production of ADP and malonyl-CoA. A CE assay for
the BC component of ACC and an optimized CE assay for the CT component of ACC have been
demonstrated. The CE assays for holo-ACC and the individual components BC and CT eliminate
disadvantages that have been associated with previously developed ACC assays such as, spectral
interference, the use of radioactive materials, consumption of large sample amounts, and indirect
monitoring, which could lead to false positives. One drawback of this CE-based method is that
the ATP and acetyl-CoA concentrations were limited to 50 M and above because UV
absorbance detection was used with a 50 m internal diameter capillary. While several of the
previously published assays for holo-ACC used ATP and acetyl-CoA concentrations above 50
M, it is desirable to have the capability to use substrate concentrations below 50 M. Because
ACC is a target for the development of therapeutic agents for metabolic syndrome (including
obesity and type 2 diabetes) and cancer as well as antibiotics and herbicides, this assay will be
beneficial for efficient inhibitor screening and could lead to new discoveries of antibiotics,
herbicides, and treatments for metabolic syndrome and cancer. Finally, the development of
methods that can directly monitor reactants and products for multiple enzyme-catalyzed
reactions will have impact beyond studying ACC.
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CHAPTER 4. IDENTIFICATION OF BACTERIAL ACETYL COA CARBOXYLASE
INHIBITORS DERIVED FROM BOTANICAL EXTRACTS
4.1.

Introduction
The development of antibiotic resistant bacteria is an emerging problem with potentially

catastrophic consequences [123, 124]. The dramatic increase in resistant bacteria in recent years
is primarily from overuse of antibiotics in both human therapy and agricultural settings [125];
however, even without overuse, bacterial resistance to an antibiotic will appear soon after its
introduction in the clinic [126]. Thus, unlike other drugs, antibiotics are only effective for a
limited time, which means there is a constant need for new antibiotics. Unfortunately, there has
been a steady decline in the number of antibiotics approved by the FDA. Only two antibiotics
were approved by the FDA from 2008-2010 [127, 128]. One reason for the lack of new
antibiotics is that the current arsenal of antibiotics is directed at a limited number of targets (<
30) [129], and there is an urgent need for new antibiotic targets. One potential new target for
antibacterial therapy is acetyl-CoA carboxylase (ACC) [98, 99, 130].
ACC catalyzes the committed and rate-limiting step in fatty acid biosynthesis in all
bacteria, plants, and animals. Since bacteria only use fatty acids for membrane biogenesis,
inhibiting the activity of ACC will limit cell wall biosynthesis, ultimately resulting in cell death
[130]. Catalysis by ACC involves the biotin-dependent carboxylation of acetyl-CoA to form
malonyl-CoA and is carried out in two half-reactions (Figure 4.1) [97]. First, the biotin
carboxylase (BC) component of ACC catalyzes the ATP-dependent carboxylation of biotin,
which is covalently attached to biotin carboxyl carrier protein (BCCP) in vivo. Second, the
carboxyltransferase (CT) component of ACC catalyzes the transfer of the carboxyl group from
biotin to acetyl-CoA to form malonyl-CoA. In bacteria, BC, CT, and BCCP are separate
proteins, and BC and CT retain their activity and can utilize free biotin in place of BCCP [97].
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Both the BC and the CT components of bacterial ACC have been validated as targets for
antibacterial development. CT was first identified as the target for the antibacterial natural
products andrimid and moiramide B [98], while BC was identified as the target for several
synthetic antibacterial agents: pyridopyrimidines [131], amino-oxazoles [99], and benzimidazole
carboxamides [132]. Although these CT and BC inhibitors showed both in vivo and in vitro
antibacterial activity against a variety of Gram-negative and Gram-positive pathogens, these
compounds never advanced to clinical testing, leaving a promising new antibacterial target
(ACC) without any new lead compounds.

Figure 4.1. Acetyl-CoA carboxylase reaction scheme.
Greater than 75% of the antibiotics used to treat infectious disease originated as natural
products,[133] but the pharmaceutical industry has largely abandoned testing for new leads
based on natural products [15, 16]. One reason botanicals remain unexplored as a primary source
of natural products is due to the inherent complexity of botanical extracts. The complex chemical
mixtures of botanical samples are often incompatible with most of the high-throughput screening
methods and assays used in the pharmaceutical industry [15, 16]. Thus, simple, efficient and
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cost-effective assays that can accommodate complex mixtures of chemicals, such as botanical
extracts, are required.
Capillary electrophoresis (CE) is a common separation technique that can be used for
quantitative enzyme assays and studying enzyme inhibition [39, 134]. Enzyme assays based on
CE are attractive for testing inhibition by complex samples like botanical extracts since spectral
interference is greatly reduced by separation of substrates, products, inhibitors and sample matrix
components. Additionally CE provides high separation efficiencies and peak capacities,
simplicity, small sample volumes (nL) and rapid analysis times [33]. Previously, we developed a
simple, off-column CE assay for the CT component of ACC using UV absorbance detection,
which eliminated spectral interference for cinnamon extracts and related molecules that could not
be assayed using the enzyme-coupled spectrophotometric method employed for the rest of the
study [116, 117]. More recently, we optimized the CT assay, developed a CE assay for BC and
reported the first assay for holo-ACC activity and inhibition that simultaneously monitored ATP,
ADP, acetyl-CoA and malonyl-CoA [135].
Herein, we report the identification of natural products that inhibit ACC, which may
serve as lead compounds for antibacterial development. These compounds were identified by
screening botanical extracts against ACC using a recently developed CE assay [135]. Based on
selected extracts that inhibited ACC in this assay, specific compounds likely to be responsible
for this inhibition were identified using a combination of literature research and computational
methods. Several of these compounds were tested for ACC inhibition using the CE assay.
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4.2.

Materials and Methods

4.2.1. Reagents and assay solutions
Acetyl coenzyme A, malonyl coenzyme A, adenosine 5’-triphosphate, adenosine 5’diphosphate, adenosine, biocytin, dimethyl sulfoxide, potassium phosphate monobasic,
potassium bicarbonate, magnesium chloride, sodium dodecyl sulfate, nutmeg oil, myricetin,
quercetin, malvidin chloride, 3,5,7-trihydroxyflavone (galangin), anrantine osage orange,
eucalyptol, terpineol, caryophyllene oxide, linalool, β-caryophyllene, α-humulene, borneol,
camphor, eugenol, estragole, carvacrol, and St. John’s Wort were purchased from Sigma-Aldrich
(St. Louis, MO). 3,6-dihydroxyflavone was purchased from Alfa Aesar (Ward Hill, MA). N-2hydroxyethylpiperazine-N′-2-ethanesulfonic acid (HEPES) was purchased from EMD Millipore
(Billerica, MA), and sodium phosphate and sodium hydroxide were purchased from Fisher
Scientific (Fair Lawn, NJ). Biotin carboxylase and carboxyltransferase from Escherichia coli
were purified as described previously [117, 120]. Biotin carboxyl carrier protein was a gift from
Pfizer. All other botanical extracts were provided by The Center for Research on Botanicals and
Metabolic Syndrome (Baton Rouge, LA). All solutions were prepared using ultrapure water (>
18 MΩ-cm, ModuLab water system, United States Filter Corp., Palm Desert, CA). All buffers
were filtered through a 0.2 μm nylon membrane (Whatman; Hillsboro, OR) prior to use for CE.
4.2.2. Capillary electrophoretic assays.
All CE assays for holo-ACC, BC and CT were performed using a P/ACE MDQ system
with UV absorbance detection (photodiode array detector) from Beckman Coulter, Inc. (Brea,
CA) as described by Bryant, et al.[135]. All solutions for the enzyme-catalyzed reaction were
prepared in 5.00 mM potassium phosphate buffer at pH 7.55 (reaction buffer). All enzyme
reactions were performed off-column in a 1.5 mL glass Beckman CE vial with a total volume of
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1.0 mL. The separation buffer for all assays contained 10.0 mM sodium phosphate and 20.0 mM
sodium dodecyl sulfate at pH 7.55. The capillary was rinsed for 30 s prior to each injection, and
the reaction mixtures were injected prior to addition of the enzyme at 1.0 min and 9.5 min after
the addition of enzyme. All electropherograms were plotted with absorbance at 256 nm.
The holo-ACC assay solution contained 25.0 µM ATP, 50.0 µM acetyl-CoA, 2.50 mM
MgCl2, 2.0 µM BCCP, 5.0 mM potassium bicarbonate and 200 μM adenosine (internal standard)
in the reaction buffer. The reaction was initiated by adding BC and CT to a final concentration of
10.0 µg/mL in the assay mixture. The BC assay mixture contained 50.0 μM ATP, 2.5 mM
MgCl2, 50.0 mM biotin, 5.0 potassium bicarbonate and 200 µM adenosine in the reaction buffer.
To initiate the reaction, BC was added to the reaction mixture to a final concentration of 20.0
µg/mL. The CT assay mixture contained 250.0 μM malonyl-CoA, 4.00 mM biocytin and 200 μM
adenosine in the reaction buffer. To initiate the reaction, CT was added to the reaction mixture to
a final concentration of 10.0 µg/mL. When botanical extracts and specific compounds were
tested for inhibition of holo-ACC, BC and CT, the extracts and compounds were added to the
reaction mixture prior to the addition of enzyme. Botanical extracts were added to the reaction
mixture at a final concentration of either 300 μg/mL or 30 μg/mL. All botanical extracts and
potential inhibitors were dissolved in either water, DMSO, methanol or ethanol according to
their solubilities (Tables 4.1, 4.2, 4.3, and 4.4). Only compounds dissolved in water or DMSO
displayed inhibition of holo-ACC. Therefore, control assays were carried out containing 1%
DMSO in the reaction mixture. It was concluded that 1% DMSO (the highest percentage of
DMSO used in these studies) did not interfere with the enzymatic reaction or the separation of
the substrates, products, and inhibitors. The ratios of the peak areas of products to substrates
(ADP / ATP and malonyl-CoA / acetyl-CoA) were used to determine whether or not inhibition
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occurred when a botanical extract or potential inhibitor were present in the solution. The ratios
obtained during the inhibition studies were compared to the ratios for a control assay that was
performed on the same day.
4.2.3. Steady State Kinetics
Biotin carboxylase activity and holo-ACC activity were both measured with a
spectrophotometric assay in which the production of ADP was coupled to pyruvate kinase and
lactate dehydrogenase, and the oxidation of NADH was monitored at 342 nm [120, 136].
Carboxyltransferase activity was measured in the reverse direction with a spectrophotometric
assay in which the production of acetyl-CoA was coupled to the combined citrate synthasemalate dehydrogenase reaction requiring NAD+ reduction [117]. All measurements were carried
out in a volume of 0.5 mL in 1 cm path length quartz cuvettes. All reaction mixtures contained
10% DMSO to ensure that quercetin remained in solution during the course of the studies.
Control assays containing 10% DMSO were also performed.
4.2.4. Ligand homology study
A computational ligand homology approach was used to identify potential inhibitors of
ACC. Quercetin was used as a model for the ligand homology studies. A variety of software was
used for the studies including eSimDock, DrugScore and AutoDock Vina software.
4.3.

Results

4.3.1. Screening of botanical extracts against holo-ACC.
A small library of botanical extracts provided by The Center for Research on Botanicals
and Metabolic Syndrome was screened for inhibition of holo acetyl-coA carboxylase with a goal
of identifying natural products that inhibit this enzyme. Many of these botanical extracts
contained molecules that absorb strongly at UV and visible wavelengths. A photo of the

64

dissolved extracts is shown in Figure 4.2. The coupled enzyme assay normally used for holoACC [136] is based on measurement of NADH absorbance at 340 nm and could not be used for
screening these extracts due to spectral interference. Instead, a recently developed CE assay for
ACC[135]

was

used

to

screen

the

botanical

extracts

for

holo-ACC

inhibition.

Figure 4.2. Sample vials containing botanical extracts (300 μg/mL).

The CE assay is less susceptible to spectral interference since substrates and products are
separated from many potential interfering species in the test samples [116, 135]. An example of
this is presented in panel A of Figure 4.3, which shows an electropherogram of a reaction
mixture containing a curcumin extract (Table 1) prior to the addition of CT and BC to initiate the
enzyme assay. Peaks are observed in panel A of Figure 4.3 for 25 µM ATP, 50 µM acetyl-CoA,
and the curcumin extract (7.9 min). Although panel A of Figure 4.3 shows absorbance at 256 nm,
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the wavelength used for this CE assay, the curcumin extract absorbs strongly at 340 nm, and
inhibition of holo-ACC could not be carried out using the more common coupled enzyme assay
due to spectral interference [116, 135].

Figure 4.3. Electropherograms for the holo-ACC assay. (A) The reaction mixture contained 300
μg/mL of curcumin extract, 25 μM ATP, 50 μM acetyl-CoA, 2.5 mM MgCl2, 2.0 μM BCCP, and
5.0 mM potassium bicarbonate prior to the addition of addition of 10.0 µg/mL of CT and 10.0
µg/mL of BC to initiate the reaction. (B) A 9.5 min after initiation of the reaction for the same
sample shown in panel A, a decreased amount of ADP and malonyl-CoA formation was
observed when compared to the control assay shown in panel C, indicating weak inhibition. (C)
Control assay (no inhibitor) at 9.5 min after the addition of CT and BC to initiate the reaction.
(D) Assay with 300 μg/mL cranberry CE at 9.5 min after the addition of CT and BC to initiate
the reaction shows no product formation, indicating inhibition.
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Panel B of Figure 4.3 shows an electropherogram 9.5 min after the addition of BC and
CT to start the assay. A small ADP peak is observed at 6.2 min, and a malonyl-CoA peak is
observed at 6.9 min, indicating that the reaction is proceeding. However, when the product
formation at 9.5 min was compared to a control assay (no extract present) at the same reaction
time (Figure 4.3, panel C), production of ADP and malonyl-CoA was significantly reduced in the
presence of the curcumin extract. An example of strong inhibition is shown in panel D of Figure
4.3 for a cranberry extract (cranberry CE, Table 4.1). In this experiment, formation of the
products ADP and malonyl-CoA was not observed even after a 9.5 min reaction time. It is
important to note that there are three extract peaks from the cranberry extract very close to ATP
and acetyl-CoA, again illustrating the importance of using the CE assay for these studies.
A total of 18 botanical extracts were blindly tested for their ability to inhibit holo-ACC
using the CE-based screening assay. At a concentration of 300 g/mL, ten of these extracts
significantly inhibited holo-ACC (Table 4.1). Strong inhibition was defined as inhibition when
the malonyl-CoA peak was below the limit of quantification at reaction time of 9.5 min. Extracts
that significantly reduced the formation of ADP and malonyl-CoA at a reaction time of 9.5 min,
but did not meet the definition of strong inhibitors were classified as weak inhibitors. The four
extracts that were strong inhibitors at 300 g/mL were diluted to 30 g/mL and tested with the
CE assay. All four of these extracts were classified as weak inhibitors at 30 g/mL.
Holo-ACC is a multifunctional enzyme composed of two enzymatic components, which
catalyze two coupled reactions, so all the extracts that inhibited holo-ACC were subsequently
screened against CT and BC separately using the CE assays developed by Bryant et al.[135]. The
results from these studies are presented in Table 4.1. All ten extracts that inhibited holo-ACC
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also inhibited CT, but the only botanical extracts that inhibited both CT and BC were two
cranberry extracts, cranberry CE and cranberry 90MX.
Table 4.1. Inhibition of holo-ACC, CT and BC by botanical extracts.*
Extract Name

Holo-ACC
Inhibition

CT
BC
Inhibition Inhibition

Solvent

Cranberry CE

Strong

Strong

Strong

Water

Cranberry 90MX

Weak

Weak

Strong

Water

Holy Basil

Strong

Strong

None

Water

Rubus Caesius

Strong

Strong

None

DMSO

Artemisia Scoparia

Strong

Weak

None

DMSO

Curcumin

Weak

Strong

None

DMSO

Inula Helenium

Weak

Strong

None

DMSO

PMI 5011 (Artemisia Dracunculus)

Weak

Weak

None

DMSO

Artemisia Rutifolia

Weak

Weak

None

DMSO

Artemisia Santolinifolia

Weak

Weak

None

DMSO

BM4 (Bitter Melon)

None

N/A

N/A

DMSO

Avocado

None

N/A

N/A

Water

BMSB (Bitter Melon)

None

N/A

N/A

Water

Inula Grandis

None

N/A

N/A

DMSO

Blueberry

None

N/A

N/A

Water

BMV (Bitter Melon)

None

N/A

N/A

DMSO

St. John’s Wort

None

N/A

NA

Ethanol

Nutmeg Oil

None

N/A

N/A

DMSO

* The final extract concentration in the reaction mixture was 300 μg/mL.
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4.3.2. Screening of specific compounds against holo-ACC
The surprising result that 10 of the 18 botanical extracts screened inhibited holo-ACC
necessitated making a choice as to which extract would be used for identification of specific
natural products that inhibit ACC. Cranberry was selected for several reasons. First, the two
cranberry extracts were the only extracts that inhibited both BC and CT in addition to holo-ACC.
An equally important rationale for concentrating on the cranberry extracts is that the chemical
makeup of cranberries is well documented in the literature [137-140], which simplifies
identification of the molecule(s) in the extracts potentially responsible for the enzyme inhibition.
The literature on the chemical composition of cranberries was studied carefully in order to
identify commercially available compounds as potential ACC inhibitors for testing.
A total of 14 compounds were identified, acquired and screened against holo-ACC. Three
of these were known to be present in cranberry extracts (Table 4.2), and the remaining
compounds were known to be present in other extracts that inhibited holo-ACC (Table 4.3). The
compounds in Table 4.2 were chosen based on their commercial availability as well as their
structural similarity to known synthetic inhibitors of BC [99, 131]. Out of 14 compounds tested,
quercetin and myricetin showed inhibition of holo-ACC activity (Table 4.2). At 250 μM,
quercetin was a weak inhibitor while myricetin was a strong inhibitor using the same criteria for
classification used for the botanical extracts. Myricetin was also tested at 25 μM and found to
inhibit holo-ACC weakly. Interestingly, malvidin, which is similar in structure to quercetin and
myricetin (Table 4.2) did not inhibit holo-ACC. Lastly, consistent with both cranberry extracts,
quercetin and myricetin also inhibited the individual half-reactions catalyzed by BC and CT.
Conventional steady-state kinetic analysis was used to study the inhibition of holo-ACC, BC and
CT by quercetin and myricetin. This study was very difficult to conduct because of spectral
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interference at 340 nm by quercetin and myricetin. The results obtained for these inhibition
studies were initially difficult to interpret. Finally it was determined that quercetin and myricetin
inhibited the coupling enzymes used in the assay. The conventional assay for holo-ACC could
not be used to study these extracts and compounds.

Table 4.2. Inhibition of holo-ACC by compounds abundant in cranberry.
Compound

Structure

Concentration Inhibition of
(μM)
Holo-ACC

Quercetin

250
25

Weak
Weak

Myricetin

250
25

Strong
Weak

Malvidin

250

None

*

These compounds were dissolved in 100% DMSO and the reaction mixtures contained 0.25%
DMSO.
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4.3.3. Ligand Homology Studies
The natural products, quercetin and myricetin, that were discovered to be holo-ACC
inhibitors based on botanical screen, can serve as structural leads to identify other compounds,
both synthetic and natural products, that inhibit holo-ACC. A straightforward computational
approach was used to search for structurally related holo-ACC inhibitors. The computational
approach taken in this study was a ligand homology analysis using eSimDock, DrugScore and
AutoDock Vina software. These ligand homology studies identified 353 molecules as potential
holo-ACC inhibitors. Of the 300 molecules identified, three were chosen for further testing based
on their structural similarity to quercetin and myricetin and their commercial availability. The
three compounds selected for analysis were: anrantine osage orange, 3,6-dihydroxyflavone, and
galangin (Table 4.4). All three compounds selected contain a carbonyl group attached to fused
six-membered rings. The compounds were analyzed for inhibition holo-ACC using the CE assay.
Anrantine osage orange was found to be a strong inhibitor of holo-ACC at 250 M, and it was a
weak inhibitor at 25 μM. Galangin and 3,6-dihydroxflavone could not be tested at 250 μM due to
low solubility, but they were tested at lower concentrations. 3,6-Dihydroxflavone weakly
inhibited holo-ACC at 25 μM and 50 μM. Galangin was a weak holo-ACC inhibitor at 200 μM
but showed no inhibition at 100 μM.
4.4.

Conclusions
The importance of developing CE assays for ACC was validated in these studies. A total

of 18 botanical extracts were screened for inhibition of holo-ACC. Using the CE assay to screen
botanical extracts resulted in reduced spectral interference, which limits traditional enzyme assay
techniques. Out of the 18 botanical extracts screened, ten inhibited holo-ACC. The ten extracts
that inhibited holo-ACC all inhibited CT, and two of the ten (both from cranberry) inhibited BC.
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Table 4.3. Compounds found in botanical extracts other than cranberry.*
Compound

Structure

Solvent

Eucalyptol

DMSO

Terpineol

DMSO

Caryophyllene
Oxide

Methanol

Linalool

DMSO

β-Caryophyllene

DMSO

*

The compounds were dissolved in their respective solvents (100%) and the final concentration
of solvent in the assay mixtures was between 0.25% and 0.32%.
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Table 4.3 continued. Compounds found in botanical extracts other than cranberry.*
Compound

Structure

Solvent

Borneol

Ethanol

Camphor

Ethanol

Eugenol

DMSO

Estragole

DMSO

Carvacrol

DMSO

α-Humulene

DMSO

*

The compounds were dissolved in their respective solvents (100%) and the final concentration
of solvent in the assay mixtures was between 0.25% and 0.32%.
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Table 4.4. Inhibition of holo-ACC by compounds identified through ligand homology studies.
Compound

Structure

Concentration
(μM)

Inhibition of
Holo-ACC

Anrantine Osage
Orange

250
25

Strong
Weak

3,6Dihydroxyflavone

50
25

Weak
Weak

Galangin

200
100

Weak
None

*

The compounds were dissolved in their respective solvents (100%) and the final concentration
of solvent in the assay mixtures was between 0.25% and 0.32%.

Furthermore, 14 specific compounds found in the botanical extracts that inhibited holo-ACC
were identified based on a detailed literature search and tested for inhibition of holo-ACC, BC
and CT. Interestingly, only quercetin and myricetin, both abundant in cranberry, showed
inhibition of holo-ACC. Quercetin and myricetin inhibited both of the individual components,
BC and CT, as well. Quercetin was used as a model for ligand homology studies and synthetic
compounds that could potentially inhibit ACC were identified based on the studies. Three
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compounds selected from the ligand homology studies were screened for holo-ACC inhibition
and found to inhibit holo-ACC. The overall strategy of using CE to identify inhibitors by initially
screening botanical extracts and ending with testing natural products or synthetic molecules that
mimic natural products, can be employed for economic and efficient identification of inhibitors
of other enzymes in the future.
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CHAPTER 5. CONCLUSIONS AND FUTURE DIRECTIONS
5.1.

Conclusions
The research presented in this dissertation resulted in the development and application of

new methods for studying enzymes and enzyme inhibition using capillary electrophoresis (CE).
In Chapter 2, a fluorescent adenosine deaminase (ADA) substrate, 2',3'-O-(2,4,6 trinitrophenyl)
adenosine (TNP-adenosine), was found to be unusually photostable and could not be
photobleached. The photostability of TNP-adenosine was compared quantitatively to that of
common OGVCE fluorophores. Of the common OGVCE fluorophores investigated, fluorescein
was found to be most susceptible to photobleaching, followed by coumarin 334 and rhodamine
110. Rhodamine B was the most photostable common OGVCE dye tested; however, the
photostability of TNP-adenosine, which did not photobleach at all, exceeded that of rhodamine
B. Another conclusion drawn from Chapter 2 was that the migration rate of a dye through a
capillary can contribute significantly to its photobleaching percentage. These studies contribute
to a better understanding of the ideal properties of a dye for OGVCE assays. This information
will be useful for determining which dyes should be used for OGVCE studies and for developing
fluorescent substrates for OGVCE-based enzyme assays.
In Chapter 3, simple, and efficient assays for studying acetyl coenzyme A carboxylase
holoenzyme (holo-ACC) activity and inhibition were developed. The first off-column CE assay
for simultaneously monitoring the two reactions catalyzed by the holo-ACC components, biotin
carboxylase (BC) and carboxyltransferase (CT), was developed. The holo-ACC substrates (ATP
and acetyl-CoA) and products (ADP and malonyl-CoA) were separated using micellar
electrokinetic chromatography (MEKC). This assay allowed for concurrent screening of
inhibitors against BC and CT by directly monitoring ATP and acetyl-CoA depletion, and the
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concomitant production of ADP and malonyl-CoA. The CE assay was also applied to test known
inhibitors of BC and CT inhibition of holo-ACC inhibition. The development of this assay is
very important because many enzymes have multiple components and simultaneous monitoring
of multiple enzyme-catalyzed reactions is desirable. Additionally, a previously reported offcolumn CE assay for only the CT component of ACC was optimized, and an off-column CE
assay for only the BC component of ACC was developed. The CE assays for holo-ACC and the
individual components, BC and CT, eliminate disadvantages that have been associated with
previously developed ACC assays such as, spectral interference, the use of radioactivity,
consumption of large amounts of enzyme, and indirect monitoring through the use of coupling
enzymes, which could lead to false positives. These CE assays will be beneficial for efficient
inhibitor screening because ACC is a target for the development of therapeutic agents for
metabolic syndrome (including obesity and type 2 diabetes), cancer, antibiotics and herbicides.
Efficient screening of compounds for inhibition of ACC could lead to new discoveries of
antibiotics, herbicides, and treatments for metabolic syndrome and cancer.
In Chapter 4, 18 botanical extracts were screened for inhibition of holo-ACC, which
further demonstrates the importance of developing CE assays for ACC. Botanical extracts are
complex samples; however, because CE is an electrophoretic separation technique, spectral
interference is reduced by separation of substrates, products, inhibitors and sample matrix
components. Out of the 18 botanical extracts screened, ten inhibited holo-ACC. The ten extracts
that inhibited holo-ACC all inhibited CT, and two of the ten (both from cranberry) inhibited BC.
Specific compounds found in the botanical extracts that inhibited holo-ACC were identified
based on a detailed literature search and tested for inhibition of holo-ACC, BC and CT. Out of
14 compounds tested, quercetin and myricetin, both abundant in cranberry, showed inhibition of
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holo-ACC. Quercetin and myricetin inhibited both of the individual components, BC and CT, as
well. Synthetic compounds identified through ligand homology studies using quercetin as a
model were also screened for holo-ACC inhibition. Three compounds identified based on the
ligand homology studies were found to inhibit holo-ACC. The overall strategy of using CE to
identify inhibitors by initially screening botanical extracts and ending with testing natural
products or synthetic molecules that mimic natural products, can be employed for economic and
efficient identification of inhibitors of other enzymes in the future.
5.2.

Future Directions
The OGVCE-LIF technique is very useful for enzyme assays because enzymes that do

not have fluorogenic substrates can be investigated. Therefore, the development of OGVCE-LIF
assays for adenosine deaminase and other enzymes that do not have fluorogenic substrates is still
desirable. Now that a better understanding of the ideal properties of a substrate for OGVCE
assays has been gained, other fluorescent adenosine derivatives [141-143] and fluorescent
adenosine nucleoside derivatives [144, 145] can be explored as potential substrates for ADA and
examined for compatibility with OGVCE in order to develop an OGVCE assay for ADA.
Furthermore, other enzymes that do not have fluorogenic substrates can also be explored for the
development of an OGVCE-LIF assay.
In Chapter 4, the assays developed in Chapter 3 were successfully used for the screening
of botanical extract and potential inhibitors for inhibition of holo-ACC, and new ACC inhibitors
were identified. Next, the antimicrobial activity of the newly discovered inhibitors will be
investigated. The information obtained from those studies will be useful in determining whether
or not these new ACC inhibitors can be used in the development of antibiotics to combat the
emerging antibiotic resistance problem. Three synthetic compounds identified through ligand
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homology studies were found to inhibit holo-ACC in Chapter 4; however, several other
compounds identified through ligand homology could also be tested for ACC inhibition. In this
dissertation, there was also strong focus on the cranberry botanical extracts, but eight other
botanical extracts were found to inhibit holo-ACC. Those eight botanical extracts will be
investigated in more detail. A literature search will be used to identify and select compounds
found in the botanical extracts that inhibit holo-ACC, and those compounds will be tested for
ACC inhibition as well. If any of the compounds show inhibition of ACC, ligand homology
studies could be used to identify other potential ACC inhibitors. Synthetic compounds identified
through ligand homology could also be screened for ACC inhibition. Finally, the antimicrobial
activity of the compounds that inhibit holo-ACC will be investigated.
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APPENDIX 1. TOWARD TOTAL AUTOMATION OF MICROFLUIDICS FOR
EXTRATERRESTIAL IN SITUANALYSIS2
The studies described herein were conducted at the National Aeronautics and Space
Agency Jet Propulsion Laboratory (NASA-JPL) and published in collaboration with other
researchers. I worked at NASA-JPL as a Summer 2010 NASA Harriett G. Jenkins Fellowship
Program Mini Research Award recipient. I submitted a proposal for the competitive award and
was selected to receive funding for my summer work at NASA-JPL. My role was to automate
lab-on-a-chip instrumentation for end-to-end analysis of amino acids. I successfully carried out
automated on-chip fluorescence derivatization of amino acids and on-chip pumping and mixing
of buffers and samples, resulting in an end-to-end analysis of amino acid samples that was
completely controlled using a computer. I achieved the automation and performed initial
optimization of the derivatization, mixing and separation steps, and further optimization of the
method to complete the work for the manuscript was performed by the other authors.
Introduction
One of the primary goals of planetary exploration is to determine the potential for past,
present, or future life on extraterrestrial bodies. Despite multiple orbiter and landed missions to
extraterrestrial bodies such as Mars and Titan, we still know relatively little about their detailed
chemical composition. Quantitative chemical compositional analysis provides vital chemical
information on the processes that shape these environments, including details on abiotic or
potentially biotic sources of organic chemistry. For example, abiotic processes lead to a racemic
statistical distribution of organic molecules, while biotic processes enrich the few organic

2

Reproduced with permission from: Mora, M. F., Greer, F., Stockman, A., Bryant, S. K., Willis,
P. Towards Automation of Microfluidics for Extraterrestrial In Situ Analysis, Analytical
Chemistry, 2011, 83 (22), 8636-8641, which was copyrighted by The American Chemical Society
in 2011.
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molecules essential for life resulting in homochirality.1-2 In order to learn as much as possible
about these environments, which may contain only trace quantities of organic material, fullyautomated instrumentation capable of sensitive analysis of a broad range of organic molecules is
needed.
Capillary electrophoresis (CE) is a powerful liquid-based chemical analytical technique
that has been widely used for the analysis of a large range of biomolecules, 3-8 including amino
acids,9-12 and thus is a well-suited technique for in situ extraterrestrial chemical analyses. CE
provides highly efficient separations with minimal sample consumption and short analysis times.
There have been significant developments in the field of CE in the last decade in miniaturization
to create portable separation and detection units.13-16 In the field of planetary exploration,
miniaturized CE systems have been incorporated into instrument prototypes for detection of life
on other planetary bodies, including Mars.17-20 CE has proven to be easily miniaturized to lab-ona-chip (LOC) systems offering great versatility, custom design, high throughput, and even lower
volumes and times of analysis.13 These microchip-CE devices (µCE) have low mass, volume,
and power requirements, making them well-suited for the scientific payloads of planetary probes.
Although several materials can be used to fabricate microchips, glass is highly suitable
for in situ planetary exploration due to its compatibility with planetary protection and
contamination control procedures used to ultrasterilize spacecraft probes and instruments.
Additionally, the surface chemistry of glass is well understood, which allows precise control of
electro-osmotic flow, yielding highly efficient and reproducible electrophoretic separations.
Finally, glass microchips have high mechanical strength, high chemical resistance, low
conductivity, and are compatible with optical detection techniques.21
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A µCE analysis requires fluidic manipulation, which involves the incorporation of valves
or switches into the design. A variety of microfabricated valves and pumps have been reported
for on-chip fluidic manipulation.22-31 Multiple devices for in situ planetary analyses have been
published based on these devices, including simple fluidic routing structures, based on
pneumatically actuated monolithic membrane microvalves.17, 19 These devices rely on a polymer
elastomer, which can be PDMS or a fluorinated polymer such as Teflon or perfloropolyether.2930

Typically, PDMS is used in the laboratory because it allows easy and for rapid prototyping.

While work to partially automate sample processing steps including fluorescent derivatization,
serial dilutions, and mixing with a standard have been reported, to date these methods have
inadequately integrated sample processing steps with sample analysis into a single device.
Although the Mars Organic Analyzer (MOA) incorporated fluidic routing features into
microfluidic systems, these methods required operator involvement and the use of PEEK tubing
interfaces between two separate microdevices. To date, these devices have not incorporated all
processing steps into a single microfluidic device. Here, we present a fully integrated four-layer
microchip electrophoresis device for end-to-end μCE analysis of amino acids. The device
consists of bonded layers of Borofloat glass wafers and a flexible PDMS membrane. We
demonstrate labeling, dilution, and separation of amino acids with this device with minimal
operator intervention. The solutions were placed in the appropriate reservoirs at the beginning of
the experiment and all subsequent fluidic manipulations were performed via a microvalve circuit
designed for autonomous investigations. The objective of this work was to develop and
demonstrate a complete system that could thus be used for future in situ extraterrestrial
exploration. All that would be required of the spacecraft probe would be to deliver an aqueous
sample to a system having the capabilities described here. To the best of our knowledge, this is
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the first report of a LOC automated end-to-end μCE analysis of amino acids where all of the
sample preparation and chemical analysis steps are performed on a single, fully integrated
device.
Experimental Section
Reagents and Solutions
All chemicals were analytical reagent grade and used as received. Sodium tetraborate
(Na2B4O7·10H2O) and sodium hydroxide were purchased from Fisher Scientific (Fair Lawn, NJ).
Isopropanol was purchased from Sigma-Aldrich (St. Louis, MO). All aqueous solutions were
prepared using 18 MΩ·cm water. The pH was adjusted using either 1 M NaOH or 1 M HCl
(Sigma-Aldrich, St. Louis, MO) and measured using a glass electrode and a digital pH meter
(Orion 290A, Thermo; Waltham, MA). L-valine, L-alanine, L-serine, glycine, and L-citrulline
were purchased from Sigma-Aldrich (Saint Louis, MO). Pacific Blue succinimidyl ester (PB)
was purchased from Invitrogen (Carlsbad, CA). Stock solutions of amino acids (10 mM in water)
and Pacific Blue (20 mM in dimethylformamide (DMF)) were prepared and kept frozen (-20 °C)
when not in use. The labeling reaction was performed on and off-chip by mixing amino acids
and PB (200 M) and allowing the reaction to proceed for at least 1 hour. The reaction was
performed in 25 mM tetraborate buffer, pH 9.2. Other amino acid solutions were prepared by
diluting the corresponding amount of stock in buffer.
Microfabrication
Multilayer microdevices were prepared as previously described with minimal
modifications.

17, 27

For the μCE / pneumatic layers, 100 mm diameter 1.1 mm thick Borofloat

wafers were coated with > 2000 Å aSi using LPCVD. The wafers were spin-coated with SPR
220-7 photoresist and patterned with the desired features. The aSi hard mask was patterned

95

using SiF6 plasma, and the Borofloat was wet-etched using 49% HF. The electrophoretic layer
was patterned first, while the pneumatic layer face was protected with blue tape. The pneumatic
layer was patterned second, while the electrophoretic layer was protected with blue tape, except
during backside alignment steps. Fluidic and electrophoretic access holes were drilled in the
wafer with a diamond-tipped drill bit then the aSi hard mask was stripped. After dipping the
wafer and a 700 mm backing wafer in AZ developer, the two wafers were manually pressed
together to create a low-temperature temporary bond. This bond was solidified by bonding
between two Macor blocks under weights at 668 °C for 12 hrs. A fluidic wafer was patterned
and etched in a similar manner, and both the bonded two-wafer stack and the fluidic wafer were
ashed with O2 plasma prior to being bonded in a 4-layer stack utilizing a 250 mm PDMS gasket
sandwiched between the glass layers.
The microfabrication process produced separation channels that were 8.5 cm long, 50 μm
wide, 20 mm deep with a 1.0 cm long cross injection channel located at 0.5 cm from the anode.
Pneumatic features were etched to 300 mm depth, while the fluidic features were etched to 150
mm depth. Holes were punched immediately post-assembly in the PDMS membrane to enable
fluidic access between the fluidic wafer and the μCE reservoirs. The assembly of the
microdevice is depicted in Figure 1. Additional fluidic reservoirs were made in 3 mm thick
PDMS using a 4 mm diameter circular punch and bonded to the uppermost glass surface of the
fluidic wafer. Finally, pipettor tips were placed in these PDMS fluidic reservoirs to hold larger
volumes (< 1 mL) when needed.
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Figure 1. Microfluidic circuit for end-to-end CE analysis. Schematic representation of A) assembly of the fourlayer device and the features of each layer, and B) microfluidic circuit layout including separation channel and CE
reservoirs: sample (S), sample waste (SW), buffer (B), and waste (W), as well as fluid reservoirs. Reservoirs
containing buffer for delivery to CE wells are R1, B2, B3, and B4. Buffer reservoir B1 is used to rinse the
processing unit to W1 (waste) between runs. The wells S, SW, B, W can be emptied to the respective waste
reservoirs W1, W3, W2, and W4. The processing unit contains reservoirs R1 to R8 for sample, standards, and
reagents handling.
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Microdevice Operation
Devices were mounted inside a polycarbonate fixture designed in our laboratory (See
Figure SI-1). The assembly was placed on the microscope stage for fluorescence detection. The
top fixture was used to make individual pneumatic connections between each of the 32
pneumatic access holes and a manifold containing 32 solenoid valves. Depending upon the state
of the solenoid valve, microvalves are either open (i.e. when solenoid is connected to vacuum) or
closed (when solenoid is connected to N2). A GAST Vacuum Pressure Pump, Xantrex XHR
300-2 DC Power Supply, National Instruments cDAQ-9172 CompactDAQ Chassis, and National
Instruments 9472 8-channel Output Module were used for this purpose. Figure 1B shows a
schematic drawing of the 32-valves device used for all the experiments described here. A
National Instruments LabView 8.5 virtual instrument interface was employed to control opening
and closing of the valves.
Microchip Capillary Electrophoresis
A LabSmith HVS448 High Voltage Sequencer (Livermore, CA) was used to control
voltages applied to electrophoresis wells during injection (25 sec) and separation (200 sec).
Laser-induced fluorescence detection was performed with a commercial Nikon Eclipse TE2000U inverted microscope system. A 405 nm Melles Griot Diode Laser (CVI Melles Griot,
Carlsbad, CA) was used for excitation and emission was detected by a CCD camera (Cascade
650, Photometrics). Tetraborate buffer (25 mM, pH 9.2) was used for labeling reactions and all
CE separations. The separation channel was conditioned before use with 0.1 M NaOH for 10
min, followed by water and buffer for 5 min each. Initial experiments to optimize labeling
conditions were performed on a commercial microchip (Micralyne Inc., Edmonton, Canada). For
the four-layer device, prior to each experiment, buffer was pumped to each reservoir and a
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baseline electropherogram was acquired. Then, the sample reservoir was emptied, the sample
was pumped into the reservoir and the CE separation was performed. After each run, the sample
was pumped in and out of the CE well for 10 cycles in order to ensure complete mixing and then
the next separation was performed. During injection, 700, 1000, 0, and 900 V were applied to
buffer, sample, sample waste, and waste respectively. After 25 sec the potentials were switched
to 3000, 1700, 1700, and -2000 V. Data was processed using PeakFit (Systat Software Inc., San
Jose CA). Electropherograms were baseline-corrected and filtered using a 0.2% Loess function.
Peak migration times were corrected using Origin 8.1 (OriginLab Corporation, Northampton,
MA) to account for run-to-run variations.
Off-Chip Fluorescence Measurements
A Fluorolog-3 Fluorescence Spectrometer (Horiba Jobin-Yvon) was used to determine
the fluorescence of solutions of Pacific Blue. Solutions were placed in quartz cuvettes (1 cm
pathlength) and the emission spectra (excitation at 405 nm, emission from 410-550 nm) were
obtained in triplicate. All spectra were obtained as a ratio of corrected signal to corrected
reference (Sc/Rc) to eliminate the effect of varying background radiation in the sample chamber;
emission intensities are in units of counts per second per microampere (cps/µA). Spectra were
processed with PeakFit (Systat Software Inc., San Jose, CA) to obtain the maximum signal.
Results and Discussion
Pacific Blue was selected as the fluorescent label for this study based on its high
extinction coefficient (46,000 cm-1M-1) that enables low limits of detection of amino acids in
extraterrestial sample extracts.20, 32 A set of five amino acids that are well-resolved by microchip
capillary electrophoresis was used as a standard mixture to demonstrate the capabilities of the
device proposed here. Among the amino acids that are expected in extraterrestrial samples,33-35
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we selected for our standard mixture two major amino acid components of meteorites 33 that have
also been produced by some abiotic model syntheses 36 (alanine and glycine), two minor
components of meteorites (serine and valine), and we also included a terrestrial contamination
marker from the urea cycle (citrulline37).
In order to optimize the sensitivity of LIF to trace quantities of amino acids, we studied
the response of a mixture of amino acids (Cit, Val, Ser, and Gly) labeled with Pacific Blue over a
range of different experimental conditions (see SI_Figure 1 and SI_Figure 2). The highest
labeling efficiency was obtained at pH ~ 9. It was also observed that a high ratio of PB to amino
acid improves the labeling efficiency, we thus selected a ratio of 20 to assure the proper labeling
of low concentrations of amino acids on the sample.
Device Characterization
The design of the microfluidic device used for all the experiments described here is
shown in Figure 1B. There are 32 valves arranged in three sets of four valves used to pump fluid
in and out of the μCE wells (B, SW, and W) and 20 valves located in the processing unit. This
unit contains eight fluidic reservoirs (R1 to R8) that can be used for storage of samples, reagents,
and standards as well as for performing all the sample pretreatment steps before electrophoretic
separation. This unit is connected to the sample μCE well (S) so any solution placed on the
fluidic reservoirs (R1 to R8) can be analyzed by the CE system.
Each microvalve consists of an etched displacement chamber on the top surface of the
pneumatic manifold wafer, an elastomeric membrane layer, and a discontinuous channel
structure on the bottom of the fluidic wafer. Applying vacuum to the displacement chamber pulls
the membrane down, opening the valve and allowing connection of the fluidic channels across
the discontinuity and movement of fluids. The valve is closed by releasing the vacuum or
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applying a slight pressure. As previously described 27, by actuating three serially connected
valves in a cycle, a self-priming diaphragm pump is created. These valves were fully
characterized by Grover et al.27 The flow rates obtained with this type of pump depend on the
dimensions of the fluidic channel, the displacement chamber volume, and the valve actuation
times. The actuation times also determine the total time required for each pumping step, so
optimization is required in order to pump the highest volume of liquid in the least possible time.
Several elastomeric polymers have been integrated with glass to form monolithic membrane
microvalve devices. While fluorinated membranes have been developed in our lab and proven
suitable for the extreme conditions associated with extraterrestrial analyses, we selected
polydimethylsiloxane (PDMS) membranes based on their ease of fabrication for rapid
prototyping.22, 27
In order to determine the optimal actuation time for our fluidic design, the volume of
water transferred in 20 cycles from R1 to its closest and farthest neighbor reservoirs, R2 and R8
respectively, was measured for actuation times ranging from 10 to 750 msec. Figure 2 shows the
pumping rate as a function of actuation time for R1 to R2 and R1 to R8 and also the total volume
displaced from R1 to R2. For the minimum-distance transfer (R1-R2), the pumping rate
decreases, but the volume increases with longer actuation times. At fast actuation times the
valves do not fully open or close in each cycle, so less volume than the maximum is transferred
in each cycle. For actuation times ³ 250 msec, the valves have enough time to fully open and
close and consequently, the volume pumped per cycle no longer increases. It can also be
observed in Figure 2 that the pumping rates for R1 to R8 are smaller than those for R1 to R2 for
actuation times less than 500 msec. Because the fluidic resistance is higher for reservoirs and
valves farther apart in the layout, longer actuation times are required to transfer the same volume
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of fluid. Even though a 500 msec actuation time increases the total time required for each cycle,
it was selected as the optimum value for the rest of the experiments because it permits a uniform
pumping rate throughout the processing unit, simplifying the operation of the system. To
evaluate chip-to-chip reproducibility, the volume pumped from R1 to each of the other reservoirs
with an actuation time of 500 msec was measured for two microfluidic devices. The average
volumes obtained for each device were (12 ± 1) mL and (11.2 ± 0.8) mL indicating that although
the alignment may be slightly different for different devices due to deviations in human hand-toeye coordination, the pumping rates are consistent. All valves remained functional after the
device was stored for a period of eight months. Additionally, we did not observe any
microdevice failure (by PDMS irreversible sealing to the glass) after approximately 100,000
actuations over a period of 10 days of continuous use.

Figure 2. Pumping rate (●) and volume (Ñ) for 20 cycles pumping from R1 to R2 (─) and R1 to
R8 (─). Volumes were measured in triplicates and error bars were calculated as the standard
deviation of the 3 measurements.
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To validate the proposed microfluidic circuit for quantitative manipulation of fluids,
serial dilutions of a 20 mM PB solution were performed both manually off-chip and on-chip in
duplicate. The fluorescence of the solutions was then measured and correlated to the expected
concentration. Figure 3 shows the signal as a function of the concentration of PB for the three
sets of sequential dilutions (20 to 0.625 mM). As can be observed in the figure, the dilutions
performed using the automated pumping system correlate well with the dilutions performed
manually off-chip, thus validating the system for quantitative handling of solutions prior to
analysis by μCE.

Figure 3. Fluorescence signal obtained for solutions of PB diluted sequentially from a 20 mM
solution, (■) off-chip, (●) on-chip repetition 1, (▲) on-chip repetition 2. Dashed line represents
the power fit for the standard dilution performed off-chip.
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End-to-End Analysis
Once the operation of the processing unit was optimized and validated, an automated
μCE end-to-end analysis of amino acids involving labeling, dilution, and spiking was performed.
For the end-to-end analysis, R1 was filled with buffer, R2 with 50 µL of PB (500 µM), R3 with
250 µL of the three unlabeled amino acid (simulated unknown sample) mixture (10 µM each),
and R8 with 250 µL of the PB-labeled amino acid standard (100 nM each). The rest of the
reservoirs were used for dilution of the labeled sample (R5 and R6) and for mixing with the
standard solution (R7). The sequences of mixing and dilutions performed are described briefly
here; more detail is provided in the Supplementary Information. The experiments were
performed in the following sequence. First, sample and dye were mixed; the solution was then
left to react for at least 1 hour and then diluted to a final concentration of 160 nM. The
processing unit was then rinsed to remove residual sample (labeled or unlabeled amino acids) to
avoid contamination or false positives. Then, buffer was pumped to each CE well (50 µL) and a
blank electropherogram was obtained (Figure 4A). The sample reservoir was emptied, filled with
the amino acid standard solution, and three electrophoretic separations were acquired (Figure
4B). After analyzing the standard, the processing unit was rinsed with buffer, S was emptied and
filled with buffer and a blank run was acquired again to assure that the system was clean. Next, S
was emptied and then filled with the on-chip labeled-sample and electropherograms were
obtained (Figure 4C). As can be observed in the figure, the sample was successfully labeled onchip. The system was then rinsed and the blank run was acquired again. Finally, the on-chip
labeled sample and the standard were mixed and pumped to S for analysis (Figure 4D). The
presence of five peaks in Figure 4D indicates that the sample and the standard were well mixed
on-chip. A dilution effect (smaller peaks) is observed for Ser and Gly, which were only present
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in the standard, and for Ala which in only present on the simulated sample. Although each
solution was measured in triplicate, Figure 4 only shows one electropherogram for clarity of data
presentation.

Figure 4. Results from a completely automated on-chip analysis of amino acid mixtures.
Labeling and analysis of amino acid mixtures on-chip. A) blank run (buffer only), B) standard
solution containing 100 nM of PB-labeled (1) Cit, (2) Val, (3) Ser, and (5) Gly. C) ~160 nM
sample of (1) Cit, (2) Val, and (4) Ala diluted from 10 µM sample labeled on-chip. D) mixture
of B) and C). Conditions: 25 mM tetraborate buffer pH = 9.2, VSEP = 5 kV.

The sensitivity of our system was tested with the standard mixture of amino acids. Figure
5 shows the calibration curves obtained manually for solutions of Cit and Gly diluted from a
stock labeled with PB. The LOD were calculated as the concentration yielding a signal-to-noise
ratio (S/N) of 3. LOD for Cit, Val, Ser, Ala, and Gly were (0.94 ± 0.01), (0.70 ± 0.01), (1.17 ±
0.02), (1.05 ± 0.01), and (1.33 ± 0.02) nM respectively.
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Due to the significant increase in capability represented by the novel microdevice
demonstrated here and the challenge of obtaining relevant samples of astrobiological interest, the
automated analysis of real samples remains outside the scope of this work. We are currently
pursuing collaborations to obtain relevant samples; their autonomous analyses will be published
separately.

Figure 5. Calibration curves for (■) Cit, (●)Gly. Conditions: 25 mM tetraborate buffer pH = 9.2,
VSEP = 6 kV. Each concentration was measured in triplicates and error bars were calculated as
the standard deviation of the 3 measurements.
Conclusions
This paper describes a novel four-layer fully-integrated microfluidic device that
successfully executes automated end-to-end microchip capillary electrophoresis analyses. The
performance of the device was demonstrated by electrophoretic analysis of a sample of amino
acids labeled, diluted, and spiked on-chip. The entire process was exclusively controlled via
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computer and the only intervention of the operator was to place the solutions in reservoirs prior
to beginning the experiment. To our knowledge, this is the first demonstration of a completely
automated end-to-end CE analysis of amino acids on a single fully-integrated microfluidic
device. This effort is critical in advancing the technology readiness level of CE systems for
future in situ spaceflight investigations to targets such as Mars, Europa, and Titan, etc. where
complete automation is required. In addition, the fully autonomous fluidic processing for
microchip capillary electrophoretic analyses reported here also has a number of terrestrial
applications, ranging from point-of-care analyses to environmental monitoring.
Supplementary Information
Optimization of Labeling Conditions
In order to optimize the sensitivity of LIF to trace quantities of amino acids, we studied
the response of a mixture of amino acids (Cit, Val, Ser, and Gly) labeled with Pacific Blue over a
range of different experimental conditions. In order to assess the effect of pH on labeling
efficiency, solutions containing 2 M of each amino acid were reacted with 200 M PB at pH
values ranging from 7.0 to 10.5. Samples were then diluted to 100 nM and separated by capillary
electrophoresis using a commercial microchip. SI_Figure 1 shows the peak area for serine as a
function of the pH when the reaction was left to proceed for 1 and 24 hours. As can be observed
in SI_Figure 1, for a 1 hour reaction, pH values between 8 and 9 give the maximum fluorescent
signal. However, when the reaction was left to proceed overnight, signals decreased for pH
values above 9. These results indicate that slow base catalyzed hydrolysis occurs after rapid
reactions at 8  pH  9. In order to obtain the highest labeling efficiency in the shortest time,
labeling reactions were performed at pH ~ 9. Thus, the degradation occurring at high pH values
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is avoided and the reaction occurs in only 1 hour. The same trend was observed for all the amino
acids and only serine is showed here for clarity.

SI_Figure 1: Fluorescent signal for 100 nM serine labeled at different pH values. Labeling reaction left to
proceed for (■) 1 hour and (●) 24 hours. Conditions: 2 M serine was reacted with 200 M PB in 25 mM
tetraborate buffer pH 9.2 Separation: 25 mM tetraborate buffer pH = 9.2, tINJ = 25 sec, VSEP = 6 kV. Peak areas
and error bars were calculated as average and standard deviation of at least three measurements.

In order to determine the effect of the amino acid concentration on the efficiency of the
labeling reaction, solutions ranging from 0.50 M to 20 M were labeled using a ratio of 2:1 (PB
to amino acid) and pH 8.5 (as suggested by the seller) and then diluted to 100 nM and analyzed
by CE. As shown in SI_Figure 2A, the peak intensities for the selected amino acids increase
with the concentration until reaching a maximum value for concentrations higher than 10 M.
These results indicate that for low concentrations of amino acids, higher amounts of Pacific Blue
are required in order to enhance the labeling efficiency. The effect of the amount of Pacific Blue
on the labeling efficiency was studied by labeling 2 M solutions of amino acids with increasing
amounts of fluorescent dye. As can be observed in SI_Figure 2B, higher ratios of PB to amino
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acid improve the labeling efficiency yielding higher peak intensities. The maximum efficiency is
reached for ratios over 20. These conditions were selected in order to assure the proper labeling
of low concentrations of amino acids on the sample.
A)

B)

SI_Figure 2. Peak intensities for 100 nM mixtures of Cit, Val, Ser, and Gly as a function of A) the concentration on
the labeling solution and B) the ratio of PB to aa.
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Control of Microfluidic Device
SI_Figure 3 shows the polycarbonate mounting fixture used to hold the microchip on the
microscope stage and also to apply vacuum/pressure to the valves.

SI_Figure 3: Picture of the microfluidic device mounted on the microscope stage through a
polycarbonate fixture design in our laboratory.

Pumping Sequences
The sequence of valve actuation for operating three serially connected valves as a
diaphragm pump is shown in SI_Table 1. Applied vacuum places a valve in the open state,
pressure places a valve in the closed state.
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SI_Table 1: Sequence of valve actuation for one cycle operating three valves as a diaphragm pump.

Step
1
2
3
4
5

Valve
2
Closed
Open
Open
Open
Closed

1
Open
Open
Closed
Closed
Closed

3
Closed
Closed
Closed
Open
Open

As can be observed in the SI_Figure 4A, for the end-to-end analysis, R1 was filled with buffer,
R2 with 50 µL of PB (300 µM), R3 with 250 µL of the three unlabeled amino acid mixture (10
µM each), and R8 with 250 µL of the four PB-labeled amino acid standard (100 nM each). The
rest of the reservoirs were used for dilution of the labeled sample (R5 and R6) and for mixing
with the standard solution. SI_Figure 4B and SI_Figure 4C depict how the fluorescent dye and
the sample were mixed and how the dilution was performed, respectively.

SI_Figure 4: Schematic drawing showing A) the assignment of fluid to each reservoir, B) the labeling step which
involves pumping PB into the amino acid (aa) sample and then mixing several times, and C) the on-chip dilution
process, consisting of three main pumping steps: buffer, sample and mixing.
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SI_Table 2 shows the sequence of pumping events employed for the end-to-end analysis
of amino acid indicating the fluidic reservoirs and valves involved. Solutions were placed in the
processing unit as indicated in SI_Figure 4. The valves are numbered from 1 to 32 according to
the diagram for the device showed in Figure 1B on the manuscript. It is worth mentioning that
the pumping of buffer to S, SW, B, and W can be executed simultaneously, although they are
shown as individual steps in the table for clarity.
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SI_Table 1: Sequences for automated end-to-end CE analysis of amino acids indicating the fluidic reservoirs and
valves involved in each step. Electrophoretic analysis is indicated as CE and it was performed in triplicates.
#
1

Process
Labeling Reaction
Pump PB to 3aa Mix
Mix
Mix

2

Rinse system
Dilution 1
Pump buffer to R4
Pump Sample to R4
Pump buffer to R4
Mix
Mix

3

4

Rinse R2
Pump buffer to R2
Empty R2
Rinse system
Dilution 2
Pump buffer to R5
Pump 3dilution 1to R5
Pump buffer to R5
Mix
Mix

5

6

Rinse system
Buffer Run
Pump buffer to S
Pump Buffer to B
Pump buffer to SW
Pump Buffer to W
CE
4aa Standard
Empty S
Pump 4aa to Waste
Pump 4aa to S
CE
Empty S
Rinse system
Pump buffer to S
Rinse system
Empty S
Rinse system

From

To

Valves

#
7

R2
R3
R2
R3
R2
B1

R3
R2
R3
R2
R3
W1

18
24
6
24
6
16

2
2
2
2
2
2

23
6
24
6
24
15

R1
R3
R1
R4
R2
R4
R2

R4
R4
R4
R2
R4
R2
R4

17
24
17
8
6
8
6

2
2
2
2
2
2
2

10
10
10
6
8
6
8

B1
R2
B1

R2
W1
W1

16
6
16

2
2
2

18
18
15

R1
R4
R1
R5
R2
R5
R2
B1

R5
R5
R5
R2
R5
R2
R5
W1

17
8
17
25
18
25
18
16

2
2
2
2
2
2
2
2

11
10
11
6
11
6
11
15

R1
B2
B3
B4

S
B
SW
W

17
7
21
29

2
5
20
30

1
3
19
31

S
R8
R8

W1
W1
S

1
14
32

2
2
2

15
15
1

S
B1
R1
B1
S
B1

W1
W1
R1
W1
W1
W1

1
16
17
16
1
16

2
2
2
2
2
2

15
15
1
15
15
15

8

9

10

Process
Buffer Run
Pump buffer to S
Pump Buffer to B
Pump buffer to SW
Pump Buffer to W
CE
3aa-PB Dilution 2
Empty S
Pump sample to W
Pump 3aa sample to S
CE
Empty S
Rinse system
Pump Buffer to S
Rinse system
Empty S
Rinse system
Buffer Run
Pump buffer to S
Pump Buffer to B
Pump buffer to SW
Pump Buffer to W
CE
3aa-PB + 4aa Std.
Pump Dil. 2 to R7
Pump 4aa to R7
Mix
Mix
Empty S
Pump Mix to Waste
Pump mix to S
CE
Empty S
Rinse system
Pump Buffer to S
Rinse system
Empty S
Rinse system
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